
<!DOCTYPE html>
<html lang="en" >
    <head >

        <meta charset="UTF-8" />
        <meta http-equiv="X-UA-Compatible" content="IE=edge" />
        <meta name="HandheldFriendly" content="True" />
        <meta name="MobileOptimized" content="320" />
        <meta name="viewport" content="width=device-width, initial-scale=1.0" />

        
        

        
        
  <link rel="stylesheet" href="/static/assets/style-8258669d.css" />
<script type="module" crossorigin="" src="/static/assets/base_style-f4a99799.js"></script>

  <link rel="stylesheet" href="/static/assets/style-ef962842.css" />
<link rel="stylesheet" href="/static/assets/style-3ade8b5c.css" />
<script type="module" crossorigin="" src="/static/assets/article_style-d757a0dd.js"></script>

  
  
    <style>
  
  
  @media screen and (min-width: 64em) {
    div.pmc-wm {
      background: repeat-y;
      background-image: url("data:image/svg+xml,%3Csvg xmlns='http://www.w3.org/2000/svg' width='20' height='350' xmlns:xlink='http://www.w3.org/1999/xlink'%3E%3Cdefs%3E%3Cfilter x='-.02' y='0' width='1.05' height='1' id='c'%3E%3CfeFlood flood-color='%23FFF'/%3E%3CfeComposite in='SourceGraphic'/%3E%3C/filter%3E%3Ctext id='b' font-family='Helvetica' font-size='11pt' style='opacity:1;fill:%23005ea2;stroke:none;text-anchor:middle' x='175' y='14'%3E%3C/text%3E%3Cpath id='a' style='fill:%23005ea2' d='M0 8h350v3H0z'/%3E%3C/defs%3E%3Cuse xlink:href='%23a' transform='rotate(90 10 10)'/%3E%3Cuse xlink:href='%23b' transform='rotate(90 10 10)' filter='url(%23c)'/%3E%3C/svg%3E");
      padding-left: 3rem;
    }
  }
</style>

  



        
            <link rel="apple-touch-icon"
                  sizes="180x180"
                  href="/static/img/favicons/apple-touch-icon.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="48x48"
                  href="/static/img/favicons/favicon-48x48.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="32x32"
                  href="/static/img/favicons/favicon-32x32.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="16x16"
                  href="/static/img/favicons/favicon-16x16.png" />
            <link rel="manifest" href="/static/img/favicons/site.webmanifest" />
            <link rel="mask-icon"
                  href="/static/img/favicons/safari-pinned-tab.svg"
                  color="#0071bc" />
            <meta name="msapplication-config"
                  content="/static/img/favicons/browserconfig.xml" />
            <meta name="theme-color" content="#ffffff" />
        

        <title>
            DEK-NUP214 monitoring before and after allogeneic haematopoietic stem cell transplantation for acute myeloid leukemia: A report from the TROPHY study group - PMC
        </title>

        
        
  
  <!-- Logging params: Pinger defaults -->
<meta name="ncbi_app" content="cloudpmc-viewer" />
<meta name="ncbi_db" content="pmc" />
<meta name="ncbi_phid" content="15251CC08AEEFC93051CC0001A8FD6ED.m_1" />
<meta name="ncbi_pinger_stat_url" content="https://pmc.ncbi.nlm.nih.gov/stat" />
<!-- Logging params: Pinger custom -->
<meta name="ncbi_pdid" content="article" />
  
    <link rel="preconnect" href="https://www.google-analytics.com" />

    
        <link rel="preconnect" href="https://cdn.ncbi.nlm.nih.gov" />
    

    <!-- Include USWDS Init Script -->
    <script src="/static/assets/uswds-init.js"></script>


    <meta name="ncbi_domain" content="jtim">
<meta name="ncbi_type" content="fulltext">
<meta name="ncbi_pcid" content="journal">
<link rel="canonical" href="https://pmc.ncbi.nlm.nih.gov/articles/PMC12371398/">
<meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE">
<meta name="citation_journal_title" content="Journal of Translational Internal Medicine">
<meta name="citation_title" content="DEK-NUP214 monitoring before and after allogeneic haematopoietic stem cell transplantation for acute myeloid leukemia: A report from the TROPHY study group">
<meta name="citation_author" content="Shuang Fan">
<meta name="citation_author_institution" content="Peking University People&#x27;s Hospital, Peking University Institute of Hematology, Beijing, China">
<meta name="citation_author" content="Yang Yang">
<meta name="citation_author_institution" content="Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei Province, China">
<meta name="citation_author" content="Shengye Lu">
<meta name="citation_author_institution" content="Peking University People&#x27;s Hospital, Peking University Institute of Hematology, Beijing, China">
<meta name="citation_author" content="Jiayu Huang">
<meta name="citation_author_institution" content="State Key Laboratory of Medical Genomics, Shanghai Institute of Hematology, National Research Center for Translational Medicine, Shanghai RuiJin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China">
<meta name="citation_author_institution" content="Collaborative Innovation Center of Hematology, Shanghai Jiao Tong University School of Medicine, Shanghai, China;">
<meta name="citation_author" content="Xiaosu Zhao">
<meta name="citation_author_institution" content="Peking University People&#x27;s Hospital, Peking University Institute of Hematology, Beijing, China">
<meta name="citation_author_institution" content="Research Unit of Key Technique for Diagnosis and Treatments of Hematologic Malignancies, Chinese Academy of Medical Sciences (2019RU029), Beijing, China">
<meta name="citation_author" content="Yang Cao">
<meta name="citation_author_institution" content="Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei Province, China">
<meta name="citation_author" content="Xiaodong Mo">
<meta name="citation_author_institution" content="Peking University People&#x27;s Hospital, Peking University Institute of Hematology, Beijing, China">
<meta name="citation_author_institution" content="Research Unit of Key Technique for Diagnosis and Treatments of Hematologic Malignancies, Chinese Academy of Medical Sciences (2019RU029), Beijing, China">
<meta name="citation_author" content="Xiaoxia Hu">
<meta name="citation_author_institution" content="State Key Laboratory of Medical Genomics, Shanghai Institute of Hematology, National Research Center for Translational Medicine, Shanghai RuiJin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China">
<meta name="citation_author_institution" content="Collaborative Innovation Center of Hematology, Shanghai Jiao Tong University School of Medicine, Shanghai, China;">
<meta name="citation_publication_date" content="2025 Jul 31">
<meta name="citation_volume" content="13">
<meta name="citation_issue" content="4">
<meta name="citation_firstpage" content="375">
<meta name="citation_doi" content="10.1515/jtim-2025-0032">
<meta name="citation_abstract_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12371398/">
<meta name="citation_fulltext_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12371398/">
<meta name="citation_pdf_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12371398/pdf/jtim-13-4-jtim-2025-0032.pdf">
<meta name="description" content="Acute myeloid leukaemia (AML) with the translocation of chromosome (6;9)(p23;q34) forms the DEK-NUP214 fusion mRNA, which is a rare subtype (~1%). Owing to the paucity of this AML subtype, comprehensive studies analysing allogeneic haematopoietic ...">
<meta name="og:title" content="DEK-NUP214 monitoring before and after allogeneic haematopoietic stem cell transplantation for acute myeloid leukemia: A report from the TROPHY study group">
<meta name="og:type" content="article">
<meta name="og:site_name" content="PubMed Central (PMC)">
<meta name="og:description" content="Acute myeloid leukaemia (AML) with the translocation of chromosome (6;9)(p23;q34) forms the DEK-NUP214 fusion mRNA, which is a rare subtype (~1%). Owing to the paucity of this AML subtype, comprehensive studies analysing allogeneic haematopoietic ...">
<meta name="og:url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12371398/">
<meta name="og:image" content="https://cdn.ncbi.nlm.nih.gov/pmc/cms/images/pmc-card-share.jpg?_=0">
<meta name="twitter:card" content="summary_large_image">
<meta name="twitter:site" content="@ncbi">
    
    

    </head>
    <body >
        
    <a class="usa-skipnav " href="#main-content">
      Skip to main content
    </a>


        
            

<section class="usa-banner " aria-label="Official website of the United States government" >
    <div class="usa-accordion">
        <header class="usa-banner__header">
            <div class="usa-banner__inner">
                <div class="grid-col-auto">
                    <img aria-hidden="true"
                         class="usa-banner__header-flag"
                         src="/static/img/us_flag.svg"
                         alt="" />
                </div>

                <div class="grid-col-fill tablet:grid-col-auto" aria-hidden="true">
                    <p class="usa-banner__header-text">
                        An official website of the United States government
                    </p>
                    <span class="usa-banner__header-action">Here's how you know</span>
                </div>

                



















    
        <button
            type="button"
        
    
    class="usa-accordion__button usa-banner__button
           

           
               
               
               
               
            

           
           
           
           "
    aria-expanded="false"
    aria-controls="gov-banner-default"
    
    data-testid="storybook-django-banner"
    
    >
    
        

        
                    <span class="usa-banner__button-text">Here's how you know</span>
                

        
    
        
            </button>
        


            </div>
        </header>

        <div class="usa-banner__content usa-accordion__content"
             id="gov-banner-default"
             hidden>
            <div class="grid-row grid-gap-lg">
                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-dot-gov.svg"
                         alt=""
                         aria-hidden="true" />
                    <div class="usa-media-block__body">
                        <p>
                            <strong>Official websites use .gov</strong>
                            <br />
                            A
                            <strong>.gov</strong> website belongs to an official
                            government organization in the United States.
                        </p>
                    </div>
                </div>

                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-https.svg"
                         alt=""
                         aria-hidden="true" />

                    <div class="usa-media-block__body">
                        <p>
                            <strong>Secure .gov websites use HTTPS</strong>
                            <br />
                            A <strong>lock</strong> (
                            <span class="icon-lock">
                                <svg xmlns="http://www.w3.org/2000/svg"
                                     width="52"
                                     height="64"
                                     viewBox="0 0 52 64"
                                     class="usa-banner__lock-image"
                                     role="graphics-symbol"
                                     aria-labelledby="banner-lock-description"
                                     focusable="false">
                                    <title id="banner-lock-title">Lock</title>
                                    <desc id="banner-lock-description">
                                    Locked padlock icon
                                    </desc>
                                    <path fill="#000000"
                                          fill-rule="evenodd"
                                          d="M26 0c10.493 0 19 8.507 19 19v9h3a4 4 0 0 1 4 4v28a4 4 0 0 1-4 4H4a4 4 0 0 1-4-4V32a4 4 0 0 1 4-4h3v-9C7 8.507 15.507 0 26 0zm0 8c-5.979 0-10.843 4.77-10.996 10.712L15 19v9h22v-9c0-6.075-4.925-11-11-11z" />
                                </svg>
</span>) or <strong>https://</strong> means you've safely
                                connected to the .gov website. Share sensitive
                                information only on official, secure websites.
                            </p>
                        </div>
                    </div>
                </div>
            </div>
        </div>
    </section>

        

        
    
    
    

<div class="usa-overlay">
</div>



<header class="usa-header usa-header--extended usa-header--wide" data-header data-testid="header"    >
    <div class="ncbi-header">
        <div class="ncbi-header__container">
            <a class="ncbi-header__logo-container"
               href="https://www.ncbi.nlm.nih.gov/">
                <img alt="NCBI home page"
                     class="ncbi-header__logo-image"
                     src="/static/img/ncbi-logos/nih-nlm-ncbi--white.svg"
                     width="410"
                     height="100" />
            </a>

            <!-- Mobile menu hamburger button -->
            



















    
        <button
            type="button"
        
    
    class="usa-menu-btn ncbi-header__hamburger-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Show menu"
    data-testid="navMenuButton"
    
    >
    
        

        
                <svg aria-hidden="true"
                     class="ncbi-hamburger-icon"
                     fill="none"
                     focusable="false"
                     height="21"
                     viewBox="0 0 31 21"
                     width="31"
                     xmlns="http://www.w3.org/2000/svg">
                    <path clip-rule="evenodd"
                          d="M0.125 20.75H30.875V17.3333H0.125V20.75ZM0.125 12.2083H30.875V8.79167H0.125V12.2083ZM0.125 0.25V3.66667H30.875V0.25H0.125Z"
                          fill="#F1F1F1"
                          fill-rule="evenodd" />
                </svg>
            

        
    
        
            </button>
        



            
                <!-- Desktop buttons-->
                <div class="ncbi-header__desktop-buttons">
                    
                        <!-- Desktop search button -->
                        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button
           "
    aria-expanded="false"
    aria-controls="search-field-desktop-navigation"
    aria-label="Show search overlay"
    data-testid="toggleSearchPanelButton"
    data-toggle-search-panel-button
    >
    
        

        
                            



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#search" />
    </svg>


                            Search
                        

        
    
        
            </button>
        


                    

                    <!-- Desktop login dropdown -->
                    
                        <div class="ncbi-header__login-dropdown">
                            



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button ncbi-header__login-dropdown-button
           "
    aria-expanded="false"
    aria-controls="login-dropdown-menu"
    aria-label="Show login menu"
    data-testid="toggleLoginMenuDropdown"
    data-desktop-login-button
    >
    
        

        
                                



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#person" />
    </svg>



                                <span data-login-dropdown-text>Log in</span>

                                <!-- Dropdown icon pointing up -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-less ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-up-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_less" />
    </svg>



                                <!-- Dropdown icon pointing down -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-more ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-down-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_more" />
    </svg>


                            

        
    
        
            </button>
        



                            <!-- Login dropdown menu -->
                            <ul class="usa-nav__submenu ncbi-header__login-dropdown-menu"
                                id="login-dropdown-menu"
                                data-desktop-login-menu-dropdown
                                hidden>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                                    </li>
                                
                                <li class="usa-nav__submenu-item">
                                    



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--outline ncbi-header__login-dropdown-logout-button
           "
    
    
    
    data-testid="desktopLogoutButton"
    data-desktop-logout-button
    >
    
        

        Log out

        
    
        
            </button>
        


                                </li>
                            </ul>
                        </div>
                    
                </div>
            
        </div>
    </div>

    <!-- Search panel -->
    
        <div class="ncbi-search-panel ncbi--show-only-at-desktop"
             data-header-search-panel
             hidden>
            <div class="ncbi-search-panel__container">
                <form action="https://www.ncbi.nlm.nih.gov/search/all/"
                      
                      autocomplete="off"
                      class="usa-search usa-search--big ncbi-search-panel__form"
                      data-testid="desktop-navigation-search-form"
                      method="GET"
                      role="search">
                    <label class="usa-sr-only" for="search-field-desktop-navigation">
                        Search…
                    </label>
                    <input class="usa-input"
                           id="search-field-desktop-navigation"
                           name="term"
                           
                               placeholder="Search NCBI"
                           
                           type="search"
                           value="" />
                    



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                        <span class="usa-search__submit-text">
                            Search NCBI
                        </span>
                    

        
    
        
            </button>
        


                </form>

                
            </div>
        </div>
    

    <nav aria-label="Primary navigation" class="usa-nav">
        <p class="usa-sr-only" id="primary-navigation-sr-only-title">
            Primary site navigation
        </p>

        <!-- Mobile menu close button -->
        



















    
        <button
            type="button"
        
    
    class="usa-nav__close ncbi-nav__close-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Close navigation menu"
    data-testid="navCloseButton"
    
    >
    
        

        
            <img src="/static/img/usa-icons/close.svg" alt="Close" />
        

        
    
        
            </button>
        



        
            <!-- Mobile search component -->
            <form class="usa-search usa-search--small ncbi--hide-at-desktop margin-top-6"
                  action="https://www.ncbi.nlm.nih.gov/search/all/"
                  
                  autocomplete="off"
                  data-testid="mobile-navigation-search-form"
                  method="GET"
                  role="search">
                <label class="usa-sr-only" for="search-field-mobile-navigation">
                    Search
                </label>

                <input class="usa-input"
                       id="search-field-mobile-navigation"
                       type="search"
                       
                           placeholder="Search NCBI"
                       
                       name="term" />

                



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                    <!-- This SVG should be kept inline and not replaced with a link to the icon as otherwise it will render in the wrong color -->
                    <img src="data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIGhlaWdodD0iMjQiIHZpZXdCb3g9IjAgMCAyNCAyNCIgd2lkdGg9IjI0Ij48cGF0aCBkPSJNMCAwaDI0djI0SDB6IiBmaWxsPSJub25lIi8+PHBhdGggZmlsbD0iI2ZmZiIgZD0iTTE1LjUgMTRoLS43OWwtLjI4LS4yN0E2LjQ3MSA2LjQ3MSAwIDAgMCAxNiA5LjUgNi41IDYuNSAwIDEgMCA5LjUgMTZjMS42MSAwIDMuMDktLjU5IDQuMjMtMS41N2wuMjcuMjh2Ljc5bDUgNC45OUwyMC40OSAxOWwtNC45OS01em0tNiAwQzcuMDEgMTQgNSAxMS45OSA1IDkuNVM3LjAxIDUgOS41IDUgMTQgNy4wMSAxNCA5LjUgMTEuOTkgMTQgOS41IDE0eiIvPjwvc3ZnPg=="
                         class="usa-search__submit-icon"
                         alt="Search" />
                

        
    
        
            </button>
        


            </form>

            
        

        <!-- Primary navigation menu items -->
        <!-- This usa-nav__inner wrapper is required to correctly style the navigation items on Desktop -->
        

        
            <div class="ncbi-nav__mobile-login-menu ncbi--hide-at-desktop"
                 data-mobile-login-menu
                 hidden>
                <p class="ncbi-nav__mobile-login-menu-status">
                    Logged in as:
                    <strong class="ncbi-nav__mobile-login-menu-email"
                            data-mobile-login-email-text></strong>
                </p>
                <ul class="usa-nav__primary usa-accordion">
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        

        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           ncbi-nav__mobile-login-button ncbi--hide-at-desktop
           "
    
    
    
    data-testid="mobileLoginButton"
    data-mobile-login-button
    >
    
        

        Log in

        
    
        
            </button>
        


    </nav>
</header>

    
    
        

<section class="pmc-header pmc-header--basic" aria-label="PMC Header with search box">
    <div class="pmc-nav-container">
        <div class="pmc-header__bar">
           <div class="pmc-header__logo">
               <a href="/" title="Home" aria-label="PMC Home"></a>
           </div>
            <button
                    type="button"
                    class="usa-button usa-button--unstyled pmc-header__search__button"
                    aria-label="Open search"
                    data-ga-category="search"
                    data-ga-action="PMC"
                    data-ga-label="pmc_search_panel_mobile"
            >
                <svg class="usa-icon width-4 height-4 pmc-icon__open" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#search"></use>
                </svg>
                <svg class="usa-icon width-4 height-4 pmc-icon__close" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
            </button>
        </div>
        <div class="pmc-header__search">
            


<form class="usa-search usa-search--extra usa-search--article-right-column  pmc-header__search__form" id="pmc-search-form" autocomplete="off" role="search">
<label class="usa-sr-only" for="pmc-search">Search PMC Full-Text Archive</label>
<span class="autoComplete_wrapper flex-1">
<input class="usa-input width-full maxw-none" required="required" placeholder="Search PMC Full-Text Archive" id="pmc-search"  type="search" name="term" data-autocomplete-url="https://pmc.ncbi.nlm.nih.gov/autocomp/search/autocomp/"/>
</span>
<button
class="usa-button"
type="submit"
formaction="https://www.ncbi.nlm.nih.gov/pmc/"
data-ga-category="search"
data-ga-action="PMC"
data-ga-label="PMC_search_button"
>
<span class="usa-search__submit-text">Search in PMC</span>
<img
src="/static/img/usa-icons-bg/search--white.svg"
class="usa-search__submit-icon"
alt="Search"
/>
</button>
</form>
            <div class="display-flex flex-column tablet:flex-row tablet:flex-justify flex-justify-center flex-align-center width-full desktop:maxw-44">
                <ul class="pmc-header__search__menu">
                    <li>
                        
                            <a class="usa-link" href="/journals/" data-ga-action="featured_link" data-ga-label="journal list">
                                Journal List
                            </a>
                        
                    </li>
                    <li>
                        
                            <a class="usa-link" href="/about/userguide/" data-ga-action="featured_link"
                            data-ga-label="user guide">
                                User Guide
                            </a>
                        
                    </li>
                </ul>
                
                    <button form="pmc-search-form" formaction="https://pmc.ncbi.nlm.nih.gov/search/" type="submit" class="usa-button usa-button--unstyled hover:text-no-underline text-no-underline width-auto margin-top-1 tablet:margin-top-0">
     <span class="bg-green-label padding-05 text-white">New</span><span class="text-underline text-primary">Try this search in PMC Beta Search</span>
</button>
                
            </div>
        </div>
    </div>
</section>

    


        
        

       
  <div class="usa-section padding-top-0 desktop:padding-top-6 pmc-article-section" data-article-db="pmc" data-article-id="12371398">

    

   



<div class="grid-container pmc-actions-bar" aria-label="Actions bar" role="complementary">
    <div class="grid-row">
        <div class="grid-col-fill display-flex">
             <div class="display-flex">
                <ul class="usa-list usa-list--unstyled usa-list--horizontal">
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <button
                                type="button"
                                class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                                aria-label="Open resources"
                                data-extra-class="is-visible-resources"
                                data-ga-category="resources_accordion"
                                data-ga-action="click"
                                data-ga-label="mobile_icon"
                        >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#more_vert"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <a
                                href="https://doi.org/10.1515/jtim-2025-0032"
                                class="usa-link display-flex usa-tooltip"
                                role="button"
                                target="_blank"
                                rel="noreferrer noopener"
                                title="View on publisher site"
                                data-position="bottom"
                                aria-label="View on publisher site"
                                data-ga-category="actions"
                                data-ga-action="click"
                                data-ga-label="publisher_link_mobile"
                        >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#launch"></use>
                                </svg>
                        </a>
                    </li>
                    
                    
                        <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                             <a
                                     href="pdf/jtim-13-4-jtim-2025-0032.pdf"
                                     class="usa-link display-flex usa-tooltip"
                                     role="button"
                                     title="Download PDF"
                                     data-position="bottom"
                                     aria-label="Download PDF"
                                     data-ga-category="actions"
                                     data-ga-action="click"
                                     data-ga-label="pdf_download_mobile"
                             >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                                </svg>
                            </a>
                        </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button
                            class="usa-button usa-button--unstyled  usa-tooltip collections-dialog-trigger collections-button display-flex collections-button-empty"
                            title="Add to Collections"
                            data-position="bottom"
                            aria-label="Save article in MyNCBI collections."
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="collections_button_mobile"
                            data-collections-open-dialog-enabled="false"
                            data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12371398%2F%3Freport%3Dclassic%23open-collections-dialog"
                            data-in-collections="false"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button role="button" class="usa-button usa-button--unstyled usa-tooltip citation-dialog-trigger display-flex"
                            aria-label="Open dialog with citation text in different styles"
                            title="Cite"
                            data-position="bottom"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="cite_mobile"
                            data-all-citations-url="/resources/citations/12371398/"
                            data-citation-style="nlm"
                            data-download-format-link="/resources/citations/12371398/export/"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="pmc-permalink display-flex" >
                         <button
                                 type="button"
                                 title="Permalink"
                                 data-position="bottom"
                                 class="usa-button usa-button--unstyled display-flex usa-tooltip"
                                 aria-label="Show article permalink"
                                 aria-expanded="false"
                                 aria-haspopup="true"
                                 data-ga-category="actions"
                                 data-ga-action="open"
                                 data-ga-label="permalink_mobile"
                         >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#share"></use>
                            </svg>
                        </button>
                        

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12371398/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
                    </li>
                </ul>
            </div>
            <button
                    type="button"
                    class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                    aria-label="Open article navigation"
                    data-extra-class="is-visible-in-page"
                    data-ga-category="actions"
                    data-ga-action="open"
                    data-ga-label="article_nav_mobile"
            >
                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#list"></use>
                </svg>
            </button>
        </div>
    </div>
</div>
    <div class="grid-container desktop:padding-left-6">
      <div id="article-container" class="grid-row grid-gap">
        <div class="grid-col-12 desktop:grid-col-8 order-2 pmc-layout__content">
            <div class="grid-container padding-left-0 padding-right-0">
                <div class="grid-row desktop:margin-left-neg-6">
                    <div class="grid-col-12">
                        <div class="pmc-layout__disclaimer" role="complementary" aria-label="Disclaimer note">
    As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with,
    the contents by NLM or the National Institutes of Health.<br/>
    Learn more:
    <a class="usa-link" data-ga-category="Link click" data-ga-action="Disclaimer" data-ga-label="New disclaimer box" href="/about/disclaimer/">PMC Disclaimer</a>
    |
    <a class="usa-link" data-ga-category="Link click" data-ga-action="PMC Copyright Notice" data-ga-label="New disclaimer box" href="/about/copyright/">
        PMC Copyright Notice
    </a>
</div>
                    </div>
                </div>
                <div class="grid-row pmc-wm desktop:margin-left-neg-6">
                    <!-- Main content -->
                    <main
                      id="main-content"
                      class="usa-layout-docs__main usa-layout-docs grid-col-12 pmc-layout pmc-prose padding-0"
                    >

                      
                        <section class="pmc-journal-banner text-center line-height-none" aria-label="Journal banner"><img src="https://cdn.ncbi.nlm.nih.gov/pmc/banners/logo-jtim.png" alt="Journal of Translational Internal Medicine logo" usemap="#pmc-banner-imagemap" width="500" height="75"><map name="pmc-banner-imagemap"><area alt="Link to Journal of Translational Internal Medicine" title="Link to Journal of Translational Internal Medicine" shape="default" href="https://www.degruyter.com/journal/key/jtim/html" target="_blank" rel="noopener noreferrer"></map></section><article lang="en"><section aria-label="Article citation and metadata"><section class="pmc-layout__citation font-secondary font-xs"><div>
<div class="display-inline-block"><button type="button" class="cursor-pointer text-no-underline bg-transparent border-0 padding-0 text-left margin-0 text-normal text-primary" aria-controls="journal_context_menu">J Transl Int Med</button></div>. 2025 Jul 31;13(4):375–385. doi: <a href="https://doi.org/10.1515/jtim-2025-0032" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">10.1515/jtim-2025-0032</a>
</div>
<nav id="journal_context_menu" hidden="hidden"><ul class="menu-list font-family-ui" role="menu">
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/pmc/?term=%22J%20Transl%20Int%20Med%22%5Bjour%5D" class="usa-link" role="menuitem">Search in PMC</a></li>
<li role="presentation"><a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22J%20Transl%20Int%20Med%22%5Bjour%5D" lang="en" class="usa-link" role="menuitem">Search in PubMed</a></li>
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22J%20Transl%20Int%20Med%22%5BTitle%20Abbreviation%5D" class="usa-link" role="menuitem">View in NLM Catalog</a></li>
<li role="presentation"><a href="?term=%22J%20Transl%20Int%20Med%22%5Bjour%5D" class="usa-link" role="menuitem" data-add-to-search="true">Add to search</a></li>
</ul></nav></section><section class="front-matter"><div class="ameta p font-secondary font-xs">
<hgroup><h1>
<em>DEK-NUP214</em> monitoring before and after allogeneic haematopoietic stem cell transplantation for acute myeloid leukemia: A report from the TROPHY study group</h1></hgroup><div class="cg p">
<a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Fan%20S%22%5BAuthor%5D" class="usa-link" aria-describedby="id1"><span class="name western">Shuang Fan</span></a><div hidden="hidden" id="id1">
<h3><span class="name western">Shuang Fan</span></h3>
<div class="p">
<sup>1</sup>Peking University People's Hospital, Peking University Institute of Hematology, Beijing, China</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Fan%20S%22%5BAuthor%5D" class="usa-link"><span class="name western">Shuang Fan</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Yang%20Y%22%5BAuthor%5D" class="usa-link" aria-describedby="id2"><span class="name western">Yang Yang</span></a><div hidden="hidden" id="id2">
<h3><span class="name western">Yang Yang</span></h3>
<div class="p">
<sup>2</sup>Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei Province, China</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Yang%20Y%22%5BAuthor%5D" class="usa-link"><span class="name western">Yang Yang</span></a>
</div>
</div>
<sup>2</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Lu%20S%22%5BAuthor%5D" class="usa-link" aria-describedby="id3"><span class="name western">Shengye Lu</span></a><div hidden="hidden" id="id3">
<h3><span class="name western">Shengye Lu</span></h3>
<div class="p">
<sup>1</sup>Peking University People's Hospital, Peking University Institute of Hematology, Beijing, China</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Lu%20S%22%5BAuthor%5D" class="usa-link"><span class="name western">Shengye Lu</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Huang%20J%22%5BAuthor%5D" class="usa-link" aria-describedby="id4"><span class="name western">Jiayu Huang</span></a><div hidden="hidden" id="id4">
<h3><span class="name western">Jiayu Huang</span></h3>
<div class="p">
<sup>3</sup>State Key Laboratory of Medical Genomics, Shanghai Institute of Hematology, National Research Center for Translational Medicine, Shanghai RuiJin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China</div>
<div class="p">
<sup>4</sup>Collaborative Innovation Center of Hematology, Shanghai Jiao Tong University School of Medicine, Shanghai, China;</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Huang%20J%22%5BAuthor%5D" class="usa-link"><span class="name western">Jiayu Huang</span></a>
</div>
</div>
<sup>3,</sup><sup>4</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Zhao%20X%22%5BAuthor%5D" class="usa-link" aria-describedby="id5"><span class="name western">Xiaosu Zhao</span></a><div hidden="hidden" id="id5">
<h3><span class="name western">Xiaosu Zhao</span></h3>
<div class="p">
<sup>1</sup>Peking University People's Hospital, Peking University Institute of Hematology, Beijing, China</div>
<div class="p">
<sup>5</sup>Research Unit of Key Technique for Diagnosis and Treatments of Hematologic Malignancies, Chinese Academy of Medical Sciences (2019RU029), Beijing, China</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Zhao%20X%22%5BAuthor%5D" class="usa-link"><span class="name western">Xiaosu Zhao</span></a>
</div>
</div>
<sup>1,</sup><sup>5</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Cao%20Y%22%5BAuthor%5D" class="usa-link" aria-describedby="id6"><span class="name western">Yang Cao</span></a><div hidden="hidden" id="id6">
<h3><span class="name western">Yang Cao</span></h3>
<div class="p">
<sup>2</sup>Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei Province, China</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Cao%20Y%22%5BAuthor%5D" class="usa-link"><span class="name western">Yang Cao</span></a>
</div>
</div>
<sup>2</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Mo%20X%22%5BAuthor%5D" class="usa-link" aria-describedby="id7"><span class="name western">Xiaodong Mo</span></a><div hidden="hidden" id="id7">
<h3><span class="name western">Xiaodong Mo</span></h3>
<div class="p">
<sup>1</sup>Peking University People's Hospital, Peking University Institute of Hematology, Beijing, China</div>
<div class="p">
<sup>5</sup>Research Unit of Key Technique for Diagnosis and Treatments of Hematologic Malignancies, Chinese Academy of Medical Sciences (2019RU029), Beijing, China</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Mo%20X%22%5BAuthor%5D" class="usa-link"><span class="name western">Xiaodong Mo</span></a>
</div>
</div>
<sup>1,</sup><sup>5,</sup><sup>✉</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Hu%20X%22%5BAuthor%5D" class="usa-link" aria-describedby="id8"><span class="name western">Xiaoxia Hu</span></a><div hidden="hidden" id="id8">
<h3><span class="name western">Xiaoxia Hu</span></h3>
<div class="p">
<sup>3</sup>State Key Laboratory of Medical Genomics, Shanghai Institute of Hematology, National Research Center for Translational Medicine, Shanghai RuiJin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China</div>
<div class="p">
<sup>4</sup>Collaborative Innovation Center of Hematology, Shanghai Jiao Tong University School of Medicine, Shanghai, China;</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Hu%20X%22%5BAuthor%5D" class="usa-link"><span class="name western">Xiaoxia Hu</span></a>
</div>
</div>
<sup>3,</sup><sup>4,</sup><sup>✉</sup>
</div>
<ul class="d-buttons inline-list">
<li><button class="d-button" aria-controls="aip_a" aria-expanded="false">Author information</button></li>
<li><button class="d-button" aria-controls="anp_a" aria-expanded="false">Article notes</button></li>
<li><button class="d-button" aria-controls="clp_a" aria-expanded="false">Copyright and License information</button></li>
</ul>
<div class="d-panels font-secondary-light">
<div id="aip_a" class="d-panel p" style="display: none">
<div class="p" id="j_jtim-2025-0032_aff_001">
<sup>1</sup>Peking University People's Hospital, Peking University Institute of Hematology, Beijing, China</div>
<div id="j_jtim-2025-0032_aff_002">
<sup>2</sup>Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei Province, China</div>
<div id="j_jtim-2025-0032_aff_003">
<sup>3</sup>State Key Laboratory of Medical Genomics, Shanghai Institute of Hematology, National Research Center for Translational Medicine, Shanghai RuiJin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China</div>
<div id="j_jtim-2025-0032_aff_004">
<sup>4</sup>Collaborative Innovation Center of Hematology, Shanghai Jiao Tong University School of Medicine, Shanghai, China;</div>
<div id="j_jtim-2025-0032_aff_005">
<sup>5</sup>Research Unit of Key Technique for Diagnosis and Treatments of Hematologic Malignancies, Chinese Academy of Medical Sciences (2019RU029), Beijing, China</div>
<div class="author-notes p">
<div class="fn" id="corresp1">
<sup>✉</sup><p class="display-inline">Xiaoxia Hu, Shanghai Institute of Hematology, National Research Center for Translational Medicine, Shanghai RuiJin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China.</p>
</div>
<div class="fn" id="corresp2">
<sup>✉</sup><p class="display-inline">Xiaodong Mo, Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing 100044, China.</p>
</div>
<div class="fn" id="_fncrsp93pmc__">
<sup>✉</sup><p class="display-inline">Corresponding author.</p>
</div>
</div>
</div>
<div id="anp_a" class="d-panel p" style="display: none"><div class="notes p"><section id="historyarticle-meta1" class="history"><p>Collection date 2025 Aug.</p></section></div></div>
<div id="clp_a" class="d-panel p" style="display: none">
<div>© 2025 Shuang Fan, Yang Yang, Shengye Lu, Jiayu Huang, Xiaosu Zhao, Yang Cao, Xiaodong Mo, Xiaoxia Hu, published by De Gruyter on behalf of the SMP</div>
<p>This work is licensed under the Creative Commons Attribution 4.0 International License.</p>
<div class="p"><a href="/about/copyright/" class="usa-link">PMC Copyright notice</a></div>
</div>
</div>
<div>PMCID: PMC12371398</div>
</div></section></section><section aria-label="Article content"><section class="body main-article-body"><section class="abstract" id="abstract1"><h2>Abstract</h2>
<section id="j_jtim-2025-0032_s_013"><h3 class="pmc_sec_title">Background and Objectives</h3>
<p>Acute myeloid leukaemia (AML) with the translocation of chromosome (6;9)(p23;q34) forms the DEK-NUP214 fusion mRNA, which is a rare subtype (~1%). Owing to the paucity of this AML subtype, comprehensive studies analysing allogeneic haematopoietic stem cell transplantation (allo-HSCT) outcomes are lacking.</p></section><section id="j_jtim-2025-0032_s_014"><h3 class="pmc_sec_title">Methods</h3>
<p>We aimed to evaluate the dynamic evolution of <em>DEK-NUP214</em> transcripts before and after allo-HSCT as well as the impact of pretransplant <em>DEK-NUP214</em> status on posttransplant outcomes in AML patients in a retrospective, multicentre study (<em>n</em> = 14).</p></section><section id="j_jtim-2025-0032_s_015"><h3 class="pmc_sec_title">Results</h3>
<p>Intermediate- or high-risk AML patients without <em>DEK-NUP214</em> transcripts receiving allo-HSCT during the same time period were enrolled as controls. Ten (71.4%) patients showed <em>DEK-NUP214</em> positivity before allo-HSCT. Except for one patient who died early after allo-HSCT, 7 out of the other 9 patients (77.8%) achieved <em>DEK-NUP214</em> negativity after allo-HSCT. The 2-year probabilities of relapse, non-relapse mortality (NRM), leukaemia-free survival (LFS), and overall survival (OS) were 14.3% (95% CI, 0%–33.6%), 35.7% (95% CI, 9.3%–62.1%), 50.0% (95% CI, 29.6%–84.4%), and 50.0% (95% CI, 29.6%–84.4%), respectively. The incidence of relapse was comparable between AML patients with and without <em>DEK-NUP214</em> transcript, but the incidence of NRM, LFS, and OS of patients with <em>DEK-NUP214</em> was poorer compared with those without <em>DEK-NUP214</em> transcript.</p></section><section id="j_jtim-2025-0032_s_016"><h3 class="pmc_sec_title">Conclusions</h3>
<p>Thus, this study observed that allo-HSCT could overcome the poor prognosis of persistent <em>DEK-NUP214</em> positivity after chemotherapy; however, new therapies should be further identified to improve the outcomes of AML patients with <em>DEK-NUP214</em>.</p></section><section id="kwd-group1" class="kwd-group"><p><strong>Key words:</strong> acute myeloid leukaemia, <em>DEK-NUP214</em> transcript, allogeneic haematopoietic stem cell transplantation, retrospective study</p></section></section><section class="abstract" id="abstract2"><h2>Graphical Abstract</h2>
<figure class="fig xbox font-sm" id="d67e192"><p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7dbd/12371398/c44d6c5162a0/jtim-2025-0032-graphabs.jpg" loading="lazy" height="444" width="771" alt="graphic file with name jtim-2025-0032-graphabs.jpg"></p>
<div class="p text-right font-secondary"><a href="figure/d67e192/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div></figure></section><section id="j_jtim-2025-0032_s_003"><h2 class="pmc_sec_title">Introduction</h2>
<p>Acute myeloid leukemia (AML) with translocation of chromosome (6;9) (p23; q34) forming the <em>DEK-NUP214</em> fusion mRNA is rare, accounting for approximately 1% of cases. It was first recognized as a distinct entity in 2008 by the World Health Organization<sup>[<a href="#j_jtim-2025-0032_ref_001" class="usa-link" aria-describedby="j_jtim-2025-0032_ref_001">1</a>]</sup> and was classified as a high-risk AML with an unfavorable prognosis according to the European LeukaemiaNet (ELN) criteria, which confers a dismal 10-year overall survival (OS) of less than 30%.<sup>[<a href="#j_jtim-2025-0032_ref_002" class="usa-link" aria-describedby="j_jtim-2025-0032_ref_002">2</a>, <a href="#j_jtim-2025-0032_ref_003" class="usa-link" aria-describedby="j_jtim-2025-0032_ref_003">3</a>, <a href="#j_jtim-2025-0032_ref_004" class="usa-link" aria-describedby="j_jtim-2025-0032_ref_004">4</a>]</sup> Previous studies indicate that the clinical outcomes of intensive chemotherapy or autologous hematopoietic stem cell transplantation are poor in patients with AML and <em>DEK-NUP214</em> fusion.<sup>[<a href="#j_jtim-2025-0032_ref_002" class="usa-link" aria-describedby="j_jtim-2025-0032_ref_002">2</a>,<a href="#j_jtim-2025-0032_ref_005" class="usa-link" aria-describedby="j_jtim-2025-0032_ref_005">5</a>]</sup> Therefore, these patients are recommended to receive allogeneic haematopoietic stem cell transplantation (allo-HSCT) at first complete remission (CR1).<sup>[<a href="#j_jtim-2025-0032_ref_006" class="usa-link" aria-describedby="j_jtim-2025-0032_ref_006">6</a>,<a href="#j_jtim-2025-0032_ref_007" class="usa-link" aria-describedby="j_jtim-2025-0032_ref_007">7</a>]</sup></p>
<p>Owing to the paucity of this AML subtype, comprehensive studies analysing allo-HSCT outcomes are lacking.<sup>[<a href="#j_jtim-2025-0032_ref_008" class="usa-link" aria-describedby="j_jtim-2025-0032_ref_008">8</a>,<a href="#j_jtim-2025-0032_ref_009" class="usa-link" aria-describedby="j_jtim-2025-0032_ref_009">9</a>]</sup> In 2012, Ishiyama <em>et al</em>.<sup>[<a href="#j_jtim-2025-0032_ref_009" class="usa-link" aria-describedby="j_jtim-2025-0032_ref_009">9</a>]</sup> conducted a matched-pair analysis of <em>de novo</em> AML patients with and without t(6;9)(p23;q34), using data obtained from the Japanese HSCT data registry. The outcomes were comparable between the two groups, suggesting that allo-HSCT may overcome the unfavorable impact of t(6:9)(p23;q34). In a recent study, Diaz-Beya <em>et al</em>.<sup>[<a href="#j_jtim-2025-0032_ref_010" class="usa-link" aria-describedby="j_jtim-2025-0032_ref_010">10</a>]</sup> reported the largest cohort of 195 patients with t(6;9)(p23;q34) receiving allo-HSCT. For patients transplanted in CR1, the 2-year probabilities of leukemia-free survival (LFS) and OS were 57% and 61%, respectively, which were equivalent to the outcomes of other intermediate-risk AML patients.<sup>[<a href="#j_jtim-2025-0032_ref_011" class="usa-link" aria-describedby="j_jtim-2025-0032_ref_011">11</a>]</sup> However, these studies did not identify the dynamic evolution of measurable residual disease (MRD, <em>i.e</em>., <em>DEK-NUP214</em> transcript) before and after allo-HSCT, or the impact of pretransplant MRD status on posttransplant outcomes.<sup>[<a href="#j_jtim-2025-0032_ref_012" class="usa-link" aria-describedby="j_jtim-2025-0032_ref_012">12</a>]</sup> In particular, whether <em>DEK-NUP214</em> transcript positivity before allo-HSCT influences posttransplant clinical outcomes remain unclear.</p>
<p>Thus, this retrospective, multicentre study aimed to evaluate the dynamic evolution of <em>DEK-NUP214</em> transcripts before and after allo-HSCT as well as the impact of pretransplant <em>DEK-NUP214</em> status on posttransplant outcomes in AML patients.</p></section><section id="j_jtim-2025-0032_s_004"><h2 class="pmc_sec_title">Materials and methods</h2>
<section id="j_jtim-2025-0032_s_004_s_001"><h3 class="pmc_sec_title">Patients</h3>
<p>This is a multicenter, retrospective study. Consecutive patients with AML and <em>DEK-NUP214</em> fusion receiving allo-HSCT at Institute of Haematology (<em>i.e</em>., TROPHY group) between March 2016 and April 2021 were enrolled. Intermediate- or high-risk AML patients without <em>DEK-NUP214</em> fusion receiving allo-HSCT during the same time period were enrolled as controls and propensity-matched (1∶3) to those with <em>DEK-NUP214</em> fusion using the nearest-neighbour method and a 2% calliper. Age, sex, donor type, and disease status were matched by propensity scores. The last follow-up was on May 1, 2023. The study was approved by the institutional review board of each participating hospital and was conducted in accordance with the Declaration of Helsinki. The requirement for written informed consent was waived owing to the retrospective nature of the study and lack of intervention in these patients.</p></section><section id="j_jtim-2025-0032_s_004_s_002"><h3 class="pmc_sec_title">Transplant regimen</h3>
<p>The protocols for the preconditioning regimen, graft-versus-host disease (GVHD) prophylaxis and treatment, and infection prophylaxis have been previously reported in detail.<sup>[<a href="#j_jtim-2025-0032_ref_007" class="usa-link" aria-describedby="j_jtim-2025-0032_ref_007">7</a>,<a href="#j_jtim-2025-0032_ref_013" class="usa-link" aria-describedby="j_jtim-2025-0032_ref_013">13</a>,<a href="#j_jtim-2025-0032_ref_014" class="usa-link" aria-describedby="j_jtim-2025-0032_ref_014">14</a>,<a href="#j_jtim-2025-0032_ref_015" class="usa-link" aria-describedby="j_jtim-2025-0032_ref_015">15</a>,<a href="#j_jtim-2025-0032_ref_016" class="usa-link" aria-describedby="j_jtim-2025-0032_ref_016">16</a>,<a href="#j_jtim-2025-0032_ref_017" class="usa-link" aria-describedby="j_jtim-2025-0032_ref_017">17</a>,<a href="#j_jtim-2025-0032_ref_018" class="usa-link" aria-describedby="j_jtim-2025-0032_ref_018">18</a>,<a href="#j_jtim-2025-0032_ref_019" class="usa-link" aria-describedby="j_jtim-2025-0032_ref_019">19</a>]</sup></p></section><section id="j_jtim-2025-0032_s_004_s_003"><h3 class="pmc_sec_title">MRD monitoring protocols</h3>
<p>The MRD status was monitored before transplantation, at 1, 2, 3, 4.5, 6, 9, and 12 months after transplantation, and at 6-month intervals thereafter.<sup>[<a href="#j_jtim-2025-0032_ref_020" class="usa-link" aria-describedby="j_jtim-2025-0032_ref_020">20</a>, <a href="#j_jtim-2025-0032_ref_021" class="usa-link" aria-describedby="j_jtim-2025-0032_ref_021">21</a>, <a href="#j_jtim-2025-0032_ref_022" class="usa-link" aria-describedby="j_jtim-2025-0032_ref_022">22</a>]</sup> Quantitative PCR was used for <em>DEK-NUP214</em> fusion monitoring.<sup>[<a href="#j_jtim-2025-0032_ref_023" class="usa-link" aria-describedby="j_jtim-2025-0032_ref_023">23</a>]</sup> Leukemia-associated aberrant immunophenotypes (LAIPs) were identified by multicolor flow cytometry (MFC), and 0.1% was used as the threshold to distinguish MRD-positive patients.<sup>[<a href="#j_jtim-2025-0032_ref_024" class="usa-link" aria-describedby="j_jtim-2025-0032_ref_024">24</a>]</sup></p></section><section id="j_jtim-2025-0032_s_004_s_004"><h3 class="pmc_sec_title">Definition</h3>
<p>Relapse was defined as recurrence of &gt; 5% bone marrow (BM) blasts, reappearance of blasts in peripheral blood, development of extramedullary disease, or recurrence of pretransplantation chromosomal abnormalities. Non-relapse mortality (NRM) was defined as death without disease progression or relapse. LFS was defined as survival with continuous CR. OS events were defined as death from any cause.</p></section><section id="j_jtim-2025-0032_s_004_s_005"><h3 class="pmc_sec_title">Statistical analysis</h3>
<p>Frequencies and percentages were used to describe patient characteristics. The Kaplan–Meier estimator was used to calculate the probabilities of survival, and a cumulative incidence function was adopted to calculate the incidence of engraftment, GVHD, relapse, and NRM using a competing risk analysis.<sup>[<a href="#j_jtim-2025-0032_ref_025" class="usa-link" aria-describedby="j_jtim-2025-0032_ref_025">25</a>]</sup> Two-sided <em>P</em> values were considered statistically significant. Statistical analyses were performed using R software 4.2.0 (<a href="http://https://www.r-project.org" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://www.r-project.org</a>) and the Statistical Package for the Social Sciences 26.0 (SPSS Inc., IBM, Armonk, NY, USA).</p></section></section><section id="j_jtim-2025-0032_s_005"><h2 class="pmc_sec_title">Results</h2>
<p>Fourteen patients were enrolled in the study (<a href="#j_jtim-2025-0032_tab_001" class="usa-link">Table 1</a> and <a href="#j_jtim-2025-0032_tab_002" class="usa-link">Table 2</a>). The distribution of other molecular abnormalities is shown in <a href="#j_jtim-2025-0032_fig_001" class="usa-link">Figure 1A</a> and <a href="#j_jtim-2025-0032_fig_001" class="usa-link">1B</a>. The median follow-up duration was 716 days (range, 7–2562 days). The clinical outcomes of the patients were as follows.</p>
<section class="tw xbox font-sm" id="j_jtim-2025-0032_tab_001"><h3 class="obj_head">Table 1.</h3>
<div class="caption p"><p>Patients characteristics</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<thead><tr>
<th align="left" rowspan="1" colspan="1">Patient</th>
<th align="left" rowspan="1" colspan="1">Age (yr)</th>
<th align="left" rowspan="1" colspan="1">Gender</th>
<th align="left" rowspan="1" colspan="1">FLT3-ITD mutations at diagnosis</th>
<th align="left" rowspan="1" colspan="1">Other molecular abnormalities at diagnosis</th>
<th align="left" rowspan="1" colspan="1">Cytogenetic at diagnosis</th>
<th align="left" rowspan="1" colspan="1">Number of courses of induction for first CR</th>
<th align="left" rowspan="1" colspan="1">Disease status before allo-HSCT</th>
<th align="left" rowspan="1" colspan="1">Donor type </th>
<th align="left" rowspan="1" colspan="1">Conditioning regimen</th>
<th align="left" rowspan="1" colspan="1">Number of HLA disparity (HLA-A, HLA-B, HLA-DR)</th>
<th align="left" rowspan="1" colspan="1">Mononuclear cell counts, ×10<sup>8</sup>/kg</th>
<th align="left" rowspan="1" colspan="1">CD34+cell counts, ×10<sup>6</sup>/kg</th>
<th align="left" rowspan="1" colspan="1">Blood group disparity</th>
<th align="left" rowspan="1" colspan="1">Donor-recipient gender match</th>
</tr></thead>
<tbody>
<tr>
<td align="left" rowspan="1" colspan="1">1</td>
<td align="left" rowspan="1" colspan="1">17</td>
<td align="left" rowspan="1" colspan="1">Male</td>
<td align="left" rowspan="1" colspan="1">Negative</td>
<td align="left" rowspan="1" colspan="1">WT1, EVI1</td>
<td align="left" rowspan="1" colspan="1">46,XY,t(6;9) (p23;q34) [17]/46,XY[3]</td>
<td align="left" rowspan="1" colspan="1">1</td>
<td align="left" rowspan="1" colspan="1">CR1</td>
<td align="left" rowspan="1" colspan="1">HLA-haploidentical related donor</td>
<td align="left" rowspan="1" colspan="1">Chemotherapy-based regimen</td>
<td align="left" rowspan="1" colspan="1">3</td>
<td align="left" rowspan="1" colspan="1">14.53</td>
<td align="left" rowspan="1" colspan="1">4.13</td>
<td align="left" rowspan="1" colspan="1">Matched</td>
<td align="left" rowspan="1" colspan="1">Male-male</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">2</td>
<td align="left" rowspan="1" colspan="1">33</td>
<td align="left" rowspan="1" colspan="1">Female</td>
<td align="left" rowspan="1" colspan="1">Negative</td>
<td align="left" rowspan="1" colspan="1">WT1, EVI1</td>
<td align="left" rowspan="1" colspan="1">46,XX,t(6;9) (p23;q34)[5]</td>
<td align="left" rowspan="1" colspan="1">1</td>
<td align="left" rowspan="1" colspan="1">CR1</td>
<td align="left" rowspan="1" colspan="1">HLA-haploidentical related donor</td>
<td align="left" rowspan="1" colspan="1">Chemotherapy-based regimen</td>
<td align="left" rowspan="1" colspan="1">3</td>
<td align="left" rowspan="1" colspan="1">12.65</td>
<td align="left" rowspan="1" colspan="1">1.79</td>
<td align="left" rowspan="1" colspan="1">Matched</td>
<td align="left" rowspan="1" colspan="1">Male-female</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">3</td>
<td align="left" rowspan="1" colspan="1">25</td>
<td align="left" rowspan="1" colspan="1">Female</td>
<td align="left" rowspan="1" colspan="1">Negative</td>
<td align="left" rowspan="1" colspan="1">WT1, EVI1</td>
<td align="left" rowspan="1" colspan="1">46, XX,t(6;9) (p23;q34)[7]/46,XX[4]</td>
<td align="left" rowspan="1" colspan="1">2</td>
<td align="left" rowspan="1" colspan="1">CR1</td>
<td align="left" rowspan="1" colspan="1">HLA-haploidentical related donor</td>
<td align="left" rowspan="1" colspan="1">Chemotherapy-based regimen</td>
<td align="left" rowspan="1" colspan="1">3</td>
<td align="left" rowspan="1" colspan="1">8.86</td>
<td align="left" rowspan="1" colspan="1">3.30</td>
<td align="left" rowspan="1" colspan="1">Matched</td>
<td align="left" rowspan="1" colspan="1">Male-female</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">4</td>
<td align="left" rowspan="1" colspan="1">30</td>
<td align="left" rowspan="1" colspan="1">Female</td>
<td align="left" rowspan="1" colspan="1">Positive</td>
<td align="left" rowspan="1" colspan="1">FLT3-ITD, TET2</td>
<td align="left" rowspan="1" colspan="1">46, XX</td>
<td align="left" rowspan="1" colspan="1">2</td>
<td align="left" rowspan="1" colspan="1">CR1</td>
<td align="left" rowspan="1" colspan="1">HLA-haploidentical related donor</td>
<td align="left" rowspan="1" colspan="1">Chemotherapy-based regimen</td>
<td align="left" rowspan="1" colspan="1">3</td>
<td align="left" rowspan="1" colspan="1">9.74</td>
<td align="left" rowspan="1" colspan="1">2.95</td>
<td align="left" rowspan="1" colspan="1">Major mismatched or minor and major mismatched</td>
<td align="left" rowspan="1" colspan="1">Male-female</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">5</td>
<td align="left" rowspan="1" colspan="1">34</td>
<td align="left" rowspan="1" colspan="1">Male</td>
<td align="left" rowspan="1" colspan="1">Negative</td>
<td align="left" rowspan="1" colspan="1">WT1, EVI1</td>
<td align="left" rowspan="1" colspan="1">46, XY,t(6;9) (p23;q34)[12]</td>
<td align="left" rowspan="1" colspan="1">2</td>
<td align="left" rowspan="1" colspan="1">CR1</td>
<td align="left" rowspan="1" colspan="1">HLA-haploidentical related donor</td>
<td align="left" rowspan="1" colspan="1">Chemotherapy-based regimen</td>
<td align="left" rowspan="1" colspan="1">3</td>
<td align="left" rowspan="1" colspan="1">7.50</td>
<td align="left" rowspan="1" colspan="1">0.78</td>
<td align="left" rowspan="1" colspan="1">Minor mismatched</td>
<td align="left" rowspan="1" colspan="1">Female-male</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">6</td>
<td align="left" rowspan="1" colspan="1">50</td>
<td align="left" rowspan="1" colspan="1">Male</td>
<td align="left" rowspan="1" colspan="1">Negative</td>
<td align="left" rowspan="1" colspan="1">0</td>
<td align="left" rowspan="1" colspan="1">46, XY</td>
<td align="left" rowspan="1" colspan="1">2</td>
<td align="left" rowspan="1" colspan="1">CR1</td>
<td align="left" rowspan="1" colspan="1">HLA-haploidentical related donor</td>
<td align="left" rowspan="1" colspan="1">Chemotherapy-based regimen</td>
<td align="left" rowspan="1" colspan="1">3</td>
<td align="left" rowspan="1" colspan="1">8.72</td>
<td align="left" rowspan="1" colspan="1">1.63</td>
<td align="left" rowspan="1" colspan="1">Minor mismatched</td>
<td align="left" rowspan="1" colspan="1">Male-male</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">7</td>
<td align="left" rowspan="1" colspan="1">49</td>
<td align="left" rowspan="1" colspan="1">Female</td>
<td align="left" rowspan="1" colspan="1">Negative</td>
<td align="left" rowspan="1" colspan="1">WT1, MLL-PTD, NPM1</td>
<td align="left" rowspan="1" colspan="1">46, XX</td>
<td align="left" rowspan="1" colspan="1">1</td>
<td align="left" rowspan="1" colspan="1">CR1</td>
<td align="left" rowspan="1" colspan="1">HLA-haploidentical related donor</td>
<td align="left" rowspan="1" colspan="1">Chemotherapy-based regimen</td>
<td align="left" rowspan="1" colspan="1">3</td>
<td align="left" rowspan="1" colspan="1">7.24</td>
<td align="left" rowspan="1" colspan="1">3.46</td>
<td align="left" rowspan="1" colspan="1">Minor mismatched</td>
<td align="left" rowspan="1" colspan="1">Male-female</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">8</td>
<td align="left" rowspan="1" colspan="1">33</td>
<td align="left" rowspan="1" colspan="1">Male</td>
<td align="left" rowspan="1" colspan="1">Negative</td>
<td align="left" rowspan="1" colspan="1">WT1</td>
<td align="left" rowspan="1" colspan="1">46, XY,t(6;9) (p23;q34)[3]</td>
<td align="left" rowspan="1" colspan="1">3</td>
<td align="left" rowspan="1" colspan="1">CR1</td>
<td align="left" rowspan="1" colspan="1">HLA-haploidentical related donor</td>
<td align="left" rowspan="1" colspan="1">Chemotherapy-based regimen</td>
<td align="left" rowspan="1" colspan="1">3</td>
<td align="left" rowspan="1" colspan="1">7.01</td>
<td align="left" rowspan="1" colspan="1">2.74</td>
<td align="left" rowspan="1" colspan="1">Matched</td>
<td align="left" rowspan="1" colspan="1">Female-male</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">9</td>
<td align="left" rowspan="1" colspan="1">53</td>
<td align="left" rowspan="1" colspan="1">Male</td>
<td align="left" rowspan="1" colspan="1">Negative</td>
<td align="left" rowspan="1" colspan="1">WT1, EVI1, MLLPTD, PRAME</td>
<td align="left" rowspan="1" colspan="1">46,XY,der(6) t(6;9) (p23;q34),der(9) del(9)(q13q22) t(6;9)</td>
<td align="left" rowspan="1" colspan="1">1</td>
<td align="left" rowspan="1" colspan="1">CR1</td>
<td align="left" rowspan="1" colspan="1">HLA-identical sibling donor</td>
<td align="left" rowspan="1" colspan="1">Chemotherapy-based regimen</td>
<td align="left" rowspan="1" colspan="1">0</td>
<td align="left" rowspan="1" colspan="1">9.39</td>
<td align="left" rowspan="1" colspan="1">1.14</td>
<td align="left" rowspan="1" colspan="1">Matched</td>
<td align="left" rowspan="1" colspan="1">Female-male</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">10</td>
<td align="left" rowspan="1" colspan="1">51</td>
<td align="left" rowspan="1" colspan="1">Male</td>
<td align="left" rowspan="1" colspan="1">Positive</td>
<td align="left" rowspan="1" colspan="1">FLT3-ITD, DEKCAN, WT1, EVI1, MLL-PTD</td>
<td align="left" rowspan="1" colspan="1">46, XY[4]</td>
<td align="left" rowspan="1" colspan="1">2</td>
<td align="left" rowspan="1" colspan="1">CR1</td>
<td align="left" rowspan="1" colspan="1">HLA-identical sibling donor</td>
<td align="left" rowspan="1" colspan="1">TBI</td>
<td align="left" rowspan="1" colspan="1">0</td>
<td align="left" rowspan="1" colspan="1">10.38</td>
<td align="left" rowspan="1" colspan="1">2.54</td>
<td align="left" rowspan="1" colspan="1">Minor mismatched</td>
<td align="left" rowspan="1" colspan="1">Male-male</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">11</td>
<td align="left" rowspan="1" colspan="1">32</td>
<td align="left" rowspan="1" colspan="1">Male</td>
<td align="left" rowspan="1" colspan="1">Negative</td>
<td align="left" rowspan="1" colspan="1">KRAS/ZRSR2</td>
<td align="left" rowspan="1" colspan="1">46, XY,t(6;9) (p22;q34)[3]</td>
<td align="left" rowspan="1" colspan="1">3</td>
<td align="left" rowspan="1" colspan="1">CR1</td>
<td align="left" rowspan="1" colspan="1">HLA-haploidentical related donor</td>
<td align="left" rowspan="1" colspan="1">Chemotherapy-based regimen</td>
<td align="left" rowspan="1" colspan="1">2</td>
<td align="left" rowspan="1" colspan="1">12.63</td>
<td align="left" rowspan="1" colspan="1">5.20</td>
<td align="left" rowspan="1" colspan="1">Matched</td>
<td align="left" rowspan="1" colspan="1">Female-male</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">12</td>
<td align="left" rowspan="1" colspan="1">24</td>
<td align="left" rowspan="1" colspan="1">Female</td>
<td align="left" rowspan="1" colspan="1">Positive</td>
<td align="left" rowspan="1" colspan="1">FlT3-ITD</td>
<td align="left" rowspan="1" colspan="1">46, XY,t(6;9) (p22;q34)[13]</td>
<td align="left" rowspan="1" colspan="1">2</td>
<td align="left" rowspan="1" colspan="1">CR1</td>
<td align="left" rowspan="1" colspan="1">HLA-haploidentical related donor</td>
<td align="left" rowspan="1" colspan="1">Chemotherapy-based regimen</td>
<td align="left" rowspan="1" colspan="1">3</td>
<td align="left" rowspan="1" colspan="1">14.22</td>
<td align="left" rowspan="1" colspan="1">4.56</td>
<td align="left" rowspan="1" colspan="1">Matched</td>
<td align="left" rowspan="1" colspan="1">Male-female</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">13</td>
<td align="left" rowspan="1" colspan="1">15</td>
<td align="left" rowspan="1" colspan="1">Female</td>
<td align="left" rowspan="1" colspan="1">Negative</td>
<td align="left" rowspan="1" colspan="1">WT1</td>
<td align="left" rowspan="1" colspan="1">46 XX[5]</td>
<td align="left" rowspan="1" colspan="1">NA</td>
<td align="left" rowspan="1" colspan="1">NR</td>
<td align="left" rowspan="1" colspan="1">HLA-haploidentical related donor</td>
<td align="left" rowspan="1" colspan="1">Chemotherapy-based regimen</td>
<td align="left" rowspan="1" colspan="1">3</td>
<td align="left" rowspan="1" colspan="1">15.00</td>
<td align="left" rowspan="1" colspan="1">7.88</td>
<td align="left" rowspan="1" colspan="1">Matched</td>
<td align="left" rowspan="1" colspan="1">Male-female</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">14</td>
<td align="left" rowspan="1" colspan="1">48</td>
<td align="left" rowspan="1" colspan="1">Female</td>
<td align="left" rowspan="1" colspan="1">Positive</td>
<td align="left" rowspan="1" colspan="1">FLT3-ITD</td>
<td align="left" rowspan="1" colspan="1">46,XY,t(6;9) (p22;q34)[11]</td>
<td align="left" rowspan="1" colspan="1">2</td>
<td align="left" rowspan="1" colspan="1">CR1</td>
<td align="left" rowspan="1" colspan="1">HLA-haploidentical related donor</td>
<td align="left" rowspan="1" colspan="1">Chemotherapy-based regimen</td>
<td align="left" rowspan="1" colspan="1">2</td>
<td align="left" rowspan="1" colspan="1">12.47</td>
<td align="left" rowspan="1" colspan="1">5.26</td>
<td align="left" rowspan="1" colspan="1">Matched</td>
<td align="left" rowspan="1" colspan="1">Male-female</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/j_jtim-2025-0032_tab_001/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p"><div class="fn" id="j_jtim-2025-0032_tfn_101"><p>Allo-HSCT: allogeneic hematopoietic stem cell transplantation; MRD: measurable residual disease; MFC: multicolor flow cytometry; N/A: not applicable.</p></div></div></section><section class="tw xbox font-sm" id="j_jtim-2025-0032_tab_002"><h3 class="obj_head">Table 2.</h3>
<div class="caption p"><p>Outcomes after preemptive and maintenance therapies</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<thead><tr>
<th align="left" rowspan="1" colspan="1">Patient</th>
<th align="left" rowspan="1" colspan="1">Maintenance therapies after allo-HSCT</th>
<th align="left" rowspan="1" colspan="1">Achieved MRD- negative at least once after allo-HSCT</th>
<th align="left" rowspan="1" colspan="1">Achieved MFC- negative at least once after allo-HSCT</th>
<th align="left" rowspan="1" colspan="1">Relapse</th>
<th align="left" rowspan="1" colspan="1">qPCR status before relapse</th>
<th align="left" rowspan="1" colspan="1">MFC status before relapse</th>
<th align="left" rowspan="1" colspan="1">Time from HSCT to relapse (days)</th>
<th align="left" rowspan="1" colspan="1">Site of relapse</th>
<th align="left" rowspan="1" colspan="1">Outcomes</th>
</tr></thead>
<tbody>
<tr>
<td align="left" rowspan="1" colspan="1">1</td>
<td align="left" rowspan="1" colspan="1">NO</td>
<td align="left" rowspan="1" colspan="1">Yes</td>
<td align="left" rowspan="1" colspan="1">Yes</td>
<td align="left" rowspan="1" colspan="1">NO</td>
<td align="left" rowspan="1" colspan="1">Negative</td>
<td align="left" rowspan="1" colspan="1">Negative</td>
<td align="left" rowspan="1" colspan="1">N/A</td>
<td align="left" rowspan="1" colspan="1">N/A</td>
<td align="left" rowspan="1" colspan="1">Leukemia-survival free</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">2</td>
<td align="left" rowspan="1" colspan="1">NO</td>
<td align="left" rowspan="1" colspan="1">Yes</td>
<td align="left" rowspan="1" colspan="1">Yes</td>
<td align="left" rowspan="1" colspan="1">NO</td>
<td align="left" rowspan="1" colspan="1">Negative</td>
<td align="left" rowspan="1" colspan="1">Negative</td>
<td align="left" rowspan="1" colspan="1">N/A</td>
<td align="left" rowspan="1" colspan="1">N/A</td>
<td align="left" rowspan="1" colspan="1">Died infection from</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">3</td>
<td align="left" rowspan="1" colspan="1">NO</td>
<td align="left" rowspan="1" colspan="1">Yes</td>
<td align="left" rowspan="1" colspan="1">Yes</td>
<td align="left" rowspan="1" colspan="1">NO</td>
<td align="left" rowspan="1" colspan="1">Negative</td>
<td align="left" rowspan="1" colspan="1">Negative</td>
<td align="left" rowspan="1" colspan="1">N/A</td>
<td align="left" rowspan="1" colspan="1">N/A</td>
<td align="left" rowspan="1" colspan="1">Leukemia-survival free</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">4</td>
<td align="left" rowspan="1" colspan="1">NO</td>
<td align="left" rowspan="1" colspan="1">Yes</td>
<td align="left" rowspan="1" colspan="1">Yes</td>
<td align="left" rowspan="1" colspan="1">NO</td>
<td align="left" rowspan="1" colspan="1">Negative</td>
<td align="left" rowspan="1" colspan="1">Negative</td>
<td align="left" rowspan="1" colspan="1">N/A</td>
<td align="left" rowspan="1" colspan="1">N/A</td>
<td align="left" rowspan="1" colspan="1">Leukemia-survival free</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">5</td>
<td align="left" rowspan="1" colspan="1">NO</td>
<td align="left" rowspan="1" colspan="1">Yes</td>
<td align="left" rowspan="1" colspan="1">Yes</td>
<td align="left" rowspan="1" colspan="1">NO</td>
<td align="left" rowspan="1" colspan="1">Negative</td>
<td align="left" rowspan="1" colspan="1">Negative</td>
<td align="left" rowspan="1" colspan="1">N/A</td>
<td align="left" rowspan="1" colspan="1">N/A</td>
<td align="left" rowspan="1" colspan="1">Leukemia-survival free</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">6</td>
<td align="left" rowspan="1" colspan="1">NO</td>
<td align="left" rowspan="1" colspan="1">Yes</td>
<td align="left" rowspan="1" colspan="1">Yes</td>
<td align="left" rowspan="1" colspan="1">NO</td>
<td align="left" rowspan="1" colspan="1">Negative</td>
<td align="left" rowspan="1" colspan="1">Negative</td>
<td align="left" rowspan="1" colspan="1">N/A</td>
<td align="left" rowspan="1" colspan="1">N/A</td>
<td align="left" rowspan="1" colspan="1">Died infection from</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">7</td>
<td align="left" rowspan="1" colspan="1">NO</td>
<td align="left" rowspan="1" colspan="1">Yes</td>
<td align="left" rowspan="1" colspan="1">Yes</td>
<td align="left" rowspan="1" colspan="1">NO</td>
<td align="left" rowspan="1" colspan="1">Negative</td>
<td align="left" rowspan="1" colspan="1">Negative</td>
<td align="left" rowspan="1" colspan="1">N/A</td>
<td align="left" rowspan="1" colspan="1">N/A</td>
<td align="left" rowspan="1" colspan="1">Leukemia-survival free</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">8</td>
<td align="left" rowspan="1" colspan="1">NO</td>
<td align="left" rowspan="1" colspan="1">Yes</td>
<td align="left" rowspan="1" colspan="1">Yes</td>
<td align="left" rowspan="1" colspan="1">NO</td>
<td align="left" rowspan="1" colspan="1">Negative</td>
<td align="left" rowspan="1" colspan="1">Negative</td>
<td align="left" rowspan="1" colspan="1">N/A</td>
<td align="left" rowspan="1" colspan="1">N/A</td>
<td align="left" rowspan="1" colspan="1">Leukemia-survival free</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">9</td>
<td align="left" rowspan="1" colspan="1">NO</td>
<td align="left" rowspan="1" colspan="1">NO</td>
<td align="left" rowspan="1" colspan="1">Yes</td>
<td align="left" rowspan="1" colspan="1">NO</td>
<td align="left" rowspan="1" colspan="1">Negative</td>
<td align="left" rowspan="1" colspan="1">Negative</td>
<td align="left" rowspan="1" colspan="1">N/A</td>
<td align="left" rowspan="1" colspan="1">N/A</td>
<td align="left" rowspan="1" colspan="1">Died heart from failure</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">10</td>
<td align="left" rowspan="1" colspan="1">NO</td>
<td align="left" rowspan="1" colspan="1">NO</td>
<td align="left" rowspan="1" colspan="1">Yes</td>
<td align="left" rowspan="1" colspan="1">Yes</td>
<td align="left" rowspan="1" colspan="1">Yes</td>
<td align="left" rowspan="1" colspan="1">Yes</td>
<td align="left" rowspan="1" colspan="1">157</td>
<td align="left" rowspan="1" colspan="1">Bone Marrow</td>
<td align="left" rowspan="1" colspan="1">Died relapse of</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">11</td>
<td align="left" rowspan="1" colspan="1">HMA</td>
<td align="left" rowspan="1" colspan="1">Yes</td>
<td align="left" rowspan="1" colspan="1">Yes</td>
<td align="left" rowspan="1" colspan="1">NO</td>
<td align="left" rowspan="1" colspan="1">Negative</td>
<td align="left" rowspan="1" colspan="1">Negative</td>
<td align="left" rowspan="1" colspan="1">N/A</td>
<td align="left" rowspan="1" colspan="1">N/A</td>
<td align="left" rowspan="1" colspan="1">Leukemia-survival free</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">12</td>
<td align="left" rowspan="1" colspan="1">sorafnib</td>
<td align="left" rowspan="1" colspan="1">Yes</td>
<td align="left" rowspan="1" colspan="1">Yes</td>
<td align="left" rowspan="1" colspan="1">NO</td>
<td align="left" rowspan="1" colspan="1">Negative</td>
<td align="left" rowspan="1" colspan="1">Negative</td>
<td align="left" rowspan="1" colspan="1">N/A</td>
<td align="left" rowspan="1" colspan="1">N/A</td>
<td align="left" rowspan="1" colspan="1">Died infection from</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">13</td>
<td align="left" rowspan="1" colspan="1">NO</td>
<td align="left" rowspan="1" colspan="1">Yes</td>
<td align="left" rowspan="1" colspan="1">Yes</td>
<td align="left" rowspan="1" colspan="1">NO</td>
<td align="left" rowspan="1" colspan="1">Negative</td>
<td align="left" rowspan="1" colspan="1">Negative</td>
<td align="left" rowspan="1" colspan="1">N/A</td>
<td align="left" rowspan="1" colspan="1">N/A</td>
<td align="left" rowspan="1" colspan="1">Died from cerebral hemorrhage</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">14</td>
<td align="left" rowspan="1" colspan="1">sorafnib</td>
<td align="left" rowspan="1" colspan="1">Yes</td>
<td align="left" rowspan="1" colspan="1">Yes</td>
<td align="left" rowspan="1" colspan="1">Yes</td>
<td align="left" rowspan="1" colspan="1">Negative</td>
<td align="left" rowspan="1" colspan="1">Negative</td>
<td align="left" rowspan="1" colspan="1">273</td>
<td align="left" rowspan="1" colspan="1">Bone Marrow</td>
<td align="left" rowspan="1" colspan="1">Died relapse of</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/j_jtim-2025-0032_tab_002/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div></section><figure class="fig xbox font-sm" id="j_jtim-2025-0032_fig_001"><h3 class="obj_head">Figure 1.</h3>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12371398_j_jtim-2025-0032_fig_001.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7dbd/12371398/78539925474f/j_jtim-2025-0032_fig_001.jpg" loading="lazy" height="272" width="608" alt="Figure 1"></a></p>
<div class="p text-right font-secondary"><a href="figure/j_jtim-2025-0032_fig_001/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>The distribution of partner genes for DEK-NUP214 (A) and types of other molecular abnormalities (B).</p></figcaption></figure><section id="j_jtim-2025-0032_s_005_s_001"><h3 class="pmc_sec_title">Engraftment</h3>
<p>Thirteen (92.8%) patients achieved neutrophil engraftment, and the median time from transplantation to neutrophil engraftment was 12 days (range, 11–20) days. Thirteen (92.8%) patients achieved platelet engraftment, and the median time from transplantation to platelet engraftment was 14 days (range, 9–83 days). The 60-day cumulative incidence of platelet engraftment after allo-HSCT was 92.3% (95% confidence interval [CI], 73.6%–100%).</p></section><section id="j_jtim-2025-0032_s_005_s_002"><h3 class="pmc_sec_title">Graft versus host disease</h3>
<p>Ten (71.4%) patients experienced acute graft versus host disease GVHD (aGVHD) after allo-HSCT, and 5 (50.0%), 4 (40.0%), 0, and 1 (10.0%) patients experienced grade I, II, III, and IV aGVHD, respectively. The cumulative incidences of grade I–IV and grade II–IV aGVHD 100 days after allo-HSCT were 71.4% (95% CI, 45.5%–97.3%) and 35.7% (95% CI, 9.3%–62.1%), respectively.</p>
<p>Six (42.9%) patients developed chronic GVHD (cGVHD) after allo-HSCT, and 0 and 4 (28.6%) patients experienced moderate and severe cGVHD, respectively. The cumulative incidences of cGVHD and severe cGVHD at 2 years after allo-HSCT were 35.7% (95% CI, 8.7%–62.7%) and 21.4% (95% CI, 0%–44.3%), respectively.</p></section><section id="j_jtim-2025-0032_s_005_s_003"><h3 class="pmc_sec_title">Evolution and relapse of measurable residual disease</h3>
<p>Three (21.4%) patients received maintenance therapy after allo-HSCT (<a href="#j_jtim-2025-0032_tab_002" class="usa-link">Table 2</a>). Two (14.3%) patients with <em>FLT3</em> mutations received <em>FLT3</em> inhibitors as maintenance therapy, and one (7.1%) patient received hypomethylation agents as maintenance therapy.</p>
<p>Ten (71.4%) patients showed <em>DEK-NUP214</em> positivity before allo-HSCT, with a median transcript level of 4.17% (range 0.03%–143.80%). Except for one patient who died early after allo-HSCT, seven of the other nine patients (77.8%) achieved negativity after allo-HSCT, and four (57.1%), two (28.6%), and one (14.3%) achieved MRD negativity at 1, 2, and 3 months after allo-HSCT, respectively.</p>
<p>Two patients exhibited persistent MRD positivity after allo-HSCT. In addition, 1 patient showed MRD positivity again after MRD negativity. Thus, 3 patients showed MRD positivity after allo-HSCT. One of them received both DLI and IFN-α treatment as preemptive intervention but failed. The other two patients died of infection and did not receive preemptive therapies. One patient experienced hematologic relapse without MRD positivity.</p>
<p>Eight (80.0%) patients showed both MFC positivity and <em>DEK-NUP214</em> positivity before allo-HSCT, with a median level of MFC-MRD of 0.55% (range 0.03%–4.50%). All patients achieved MFC negativity, and seven (87.5%) and one (22.5%) achieved MFC negativity at 1 and 2 months after allo-HSCT, respectively.</p>
<p>Two patients experienced relapse at 157 and 273 days after allo-HSCT and died 336 and 410 days after relapse, respectively. The cumulative incidence of relapse 2 years after allo-HSCT was 14.3% (95% CI, 0%–33.6%) (<a href="#j_jtim-2025-0032_fig_002" class="usa-link">Figure 2A</a>). The 2-year cumulative incidence of relapse after allo-HSCT was 10.0% (95% CI, 0%–30.1%) and 25.0% (95% CI, 0%–74.0%) for patients with <em>DEK-NUP214</em> positivity and negativity, respectively, before allo-HSCT (<em>P</em> = 0.528).</p>
<figure class="fig xbox font-sm" id="j_jtim-2025-0032_fig_002"><h4 class="obj_head">Figure 2.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7dbd/12371398/a73fb792fbc0/j_jtim-2025-0032_fig_002.jpg" loading="lazy" height="617" width="766" alt="Figure 2"></p>
<div class="p text-right font-secondary"><a href="figure/j_jtim-2025-0032_fig_002/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>The 2-year probability of clinical outcomes after allo-HSCT, relapse (A), nonrelapse mortality (B), leukaemia-free survival (C), and overall survival (D).</p></figcaption></figure></section><section id="j_jtim-2025-0032_s_005_s_004"><h3 class="pmc_sec_title">NRM, LFS, and OS</h3>
<p>Five patients died of NRM. The most common cause of NRM was infection (<em>n</em> = 3), followed by cerebral hemorrhage (<em>n</em> = 1) and heart failure (<em>n</em> = 1). The cumulative incidence of NRM 2 years after allo-HSCT was 35.7% (95% CI, 9.3%–62.1%) (<a href="#j_jtim-2025-0032_fig_002" class="usa-link">Figure 2B</a>). The 2-year cumulative incidence of NRM after allo-HSCT was 50.0% (95% CI, 16.3%–83.7%) and 0% for patients with <em>DEK-NUP214</em> positivity and negativity before allo-HSCT, respectively (<em>P</em> = 0.100).</p>
<p>The probability of LFS 2 years after allo-HSCT was 50.0% (95% CI, 29.6%–84.4%) (<a href="#j_jtim-2025-0032_fig_002" class="usa-link">Figure 2C</a>). The 2-year probabilities of LFS after allo-HSCT were 40.0% (95% CI, 18.7%–85.5%) and 75.0% (95% CI, 42.6%–100.0%) for patients with <em>DEK-NUP214</em> positivity and negativity, respectively, before allo-HSCT (<em>P</em> = 0.230).</p>
<p>The probability of OS 2 years after allo-HSCT was 50.0% (95% CI, 29.6%–84.4%) (<a href="#j_jtim-2025-0032_fig_002" class="usa-link">Figure 2D</a>). The 2-year probabilities of OS after allo-HSCT were 40.0% (95% CI, 18.7%–85.5%) and 75.0% (95% CI, 42.6%–100.0%) for patients with <em>DEK-NUP214</em> positivity and negativity, respectively, before allo-HSCT (<em>P</em> = 0.200).</p></section><section id="j_jtim-2025-0032_s_005_s_005"><h3 class="pmc_sec_title">Comparison between AML patients with and without <em>DEK-NUP214</em>
</h3>
<p>The characteristics of patients with <em>the DEK-NUP214</em> transcript and intermediate-or high-risk AML patients without <em>the DEK-NUP214</em> transcript are shown in <a href="#j_jtim-2025-0032_tab_003" class="usa-link">Table 3</a>. The 2-year cumulative incidence of relapse after allo-HSCT was comparable between the two cohorts (<a href="#j_jtim-2025-0032_fig_003" class="usa-link">Figure 3A</a>). However, the 2-year cumulative incidence of NRM after allo-HSCT in patients with <em>DEK-NUP214</em> transcripts was higher than that in patients without <em>DEK-NUP214</em> transcripts (<a href="#j_jtim-2025-0032_fig_003" class="usa-link">Figure 3B</a>). The 2-year probabilities of OS and LFS after allo-HSCT in patients with <em>DEK-NUP214</em> transcripts were poorer than those in patients without <em>DEK-NUP214</em> transcripts (<a href="#j_jtim-2025-0032_fig_003" class="usa-link">Figure 3C</a> and <a href="#j_jtim-2025-0032_fig_002" class="usa-link">3D</a>).</p>
<section class="tw xbox font-sm" id="j_jtim-2025-0032_tab_003"><h4 class="obj_head">Table 3.</h4>
<div class="caption p"><p>Differences in characteristics between patients with and without DEK-NUP214 transcript</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<thead><tr>
<th align="left" rowspan="1" colspan="1">Characteristics</th>
<th align="left" rowspan="1" colspan="1">With DEK-NUP214 transcript (<em>n</em> = 14)</th>
<th align="left" rowspan="1" colspan="1">Without DEK-NUP214 transcript (<em>n</em> = 42)</th>
<th align="left" rowspan="1" colspan="1">
<em>P</em> value</th>
</tr></thead>
<tbody>
<tr>
<td align="left" rowspan="1" colspan="1">Median age at allo-HSCT, years (range)</td>
<td align="left" rowspan="1" colspan="1">33.2 (15–53)</td>
<td align="left" rowspan="1" colspan="1">33.4 (14–57)</td>
<td align="left" rowspan="1" colspan="1">0.985</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Gender, <em>n</em> (%)</td>
<td align="left" rowspan="1" colspan="1"></td>
<td align="left" rowspan="1" colspan="1"></td>
<td align="left" rowspan="1" colspan="1">1.000</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">    Male</td>
<td align="left" rowspan="1" colspan="1">7 (50)</td>
<td align="left" rowspan="1" colspan="1">21 (50)</td>
<td align="left" rowspan="1" colspan="1"></td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">    Female</td>
<td align="left" rowspan="1" colspan="1">7 (50)</td>
<td align="left" rowspan="1" colspan="1">21 (50)</td>
<td align="left" rowspan="1" colspan="1"></td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Induction courses for first CR, median (range)</td>
<td align="left" rowspan="1" colspan="1">2 (1–3)</td>
<td align="left" rowspan="1" colspan="1">1 (1–2)</td>
<td align="left" rowspan="1" colspan="1">0.007</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Disease status before allo-HSCT, <em>n</em> (%)</td>
<td align="left" rowspan="1" colspan="1"></td>
<td align="left" rowspan="1" colspan="1"></td>
<td align="left" rowspan="1" colspan="1">0.250</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">    CR1</td>
<td align="left" rowspan="1" colspan="1">13 (98.2)</td>
<td align="left" rowspan="1" colspan="1">42 (100.0)</td>
<td align="left" rowspan="1" colspan="1"></td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">    &gt; CR1</td>
<td align="left" rowspan="1" colspan="1">1 (1.8)</td>
<td align="left" rowspan="1" colspan="1">0 (0)</td>
<td align="left" rowspan="1" colspan="1"></td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">HCT-CI scores before allo-HSCT, <em>n</em> (%)</td>
<td align="left" rowspan="1" colspan="1"></td>
<td align="left" rowspan="1" colspan="1"></td>
<td align="left" rowspan="1" colspan="1">0.009</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">    0 (low risk)</td>
<td align="left" rowspan="1" colspan="1">11 (78.6)</td>
<td align="left" rowspan="1" colspan="1">30 (71.4)</td>
<td align="left" rowspan="1" colspan="1"></td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">    1–2 (intermediate risk)</td>
<td align="left" rowspan="1" colspan="1">2 (14.3)</td>
<td align="left" rowspan="1" colspan="1">10 (23.8)</td>
<td align="left" rowspan="1" colspan="1"></td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">    ≥ 3 (high risk)</td>
<td align="left" rowspan="1" colspan="1">1 (7.1)</td>
<td align="left" rowspan="1" colspan="1">2 (4.8)</td>
<td align="left" rowspan="1" colspan="1"></td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">ELN risk</td>
<td align="left" rowspan="1" colspan="1"></td>
<td align="left" rowspan="1" colspan="1"></td>
<td align="left" rowspan="1" colspan="1">0.001</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">    Intermediate risk</td>
<td align="left" rowspan="1" colspan="1">2</td>
<td align="left" rowspan="1" colspan="1">28</td>
<td align="left" rowspan="1" colspan="1"></td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">    High risk</td>
<td align="left" rowspan="1" colspan="1">12</td>
<td align="left" rowspan="1" colspan="1">14</td>
<td align="left" rowspan="1" colspan="1"></td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Conditioning regimen, <em>n</em> (%)</td>
<td align="left" rowspan="1" colspan="1"></td>
<td align="left" rowspan="1" colspan="1"></td>
<td align="left" rowspan="1" colspan="1">0.250</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">    Chemotherapy-based regimen</td>
<td align="left" rowspan="1" colspan="1">13 (92.9)</td>
<td align="left" rowspan="1" colspan="1">42 (100.0)</td>
<td align="left" rowspan="1" colspan="1"></td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">    TBI-based regimen</td>
<td align="left" rowspan="1" colspan="1">1 (7.1)</td>
<td align="left" rowspan="1" colspan="1">0 (0)</td>
<td align="left" rowspan="1" colspan="1"></td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Donor/recipient gender matched, <em>n</em> (%)</td>
<td align="left" rowspan="1" colspan="1"></td>
<td align="left" rowspan="1" colspan="1"></td>
<td align="left" rowspan="1" colspan="1">0.247</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">    Female donor/male recipient combination</td>
<td align="left" rowspan="1" colspan="1">4 (28.6)</td>
<td align="left" rowspan="1" colspan="1">6 (14.3)</td>
<td align="left" rowspan="1" colspan="1"></td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">    Others</td>
<td align="left" rowspan="1" colspan="1">10 (71.4)</td>
<td align="left" rowspan="1" colspan="1">36 (85.7)</td>
<td align="left" rowspan="1" colspan="1"></td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Donor/recipient relation, <em>n</em> (%)</td>
<td align="left" rowspan="1" colspan="1"></td>
<td align="left" rowspan="1" colspan="1"></td>
<td align="left" rowspan="1" colspan="1">1.000</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">    Maternal donor</td>
<td align="left" rowspan="1" colspan="1">0 (0)</td>
<td align="left" rowspan="1" colspan="1">2 (4.8)</td>
<td align="left" rowspan="1" colspan="1"></td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">    Collateral donor</td>
<td align="left" rowspan="1" colspan="1">0 (0)</td>
<td align="left" rowspan="1" colspan="1">2 (4.8)</td>
<td align="left" rowspan="1" colspan="1"></td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">    Others</td>
<td align="left" rowspan="1" colspan="1">14 (100.0)</td>
<td align="left" rowspan="1" colspan="1">38 (90.4)</td>
<td align="left" rowspan="1" colspan="1"></td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Blood group disparity, <em>n</em> (%)</td>
<td align="left" rowspan="1" colspan="1"></td>
<td align="left" rowspan="1" colspan="1"></td>
<td align="left" rowspan="1" colspan="1">0.196</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">    matched</td>
<td align="left" rowspan="1" colspan="1">9 (58.9)</td>
<td align="left" rowspan="1" colspan="1">24 (57.1)</td>
<td align="left" rowspan="1" colspan="1"></td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">    minor mismatched</td>
<td align="left" rowspan="1" colspan="1">4 (28.6)</td>
<td align="left" rowspan="1" colspan="1">6 (14.3)</td>
<td align="left" rowspan="1" colspan="1"></td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">    major mismatched or minor and major mismatched</td>
<td align="left" rowspan="1" colspan="1">1 (7.1)</td>
<td align="left" rowspan="1" colspan="1">12 (8.6)</td>
<td align="left" rowspan="1" colspan="1"></td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">MNC counts in graft, median (range, ×108/kg)</td>
<td align="left" rowspan="1" colspan="1">10.1 (7.0–15.0)</td>
<td align="left" rowspan="1" colspan="1">8.4 (6.1–13.6)</td>
<td align="left" rowspan="1" colspan="1">0.024</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">CD34+ cell counts in graft, median (range, ×106/kg)</td>
<td align="left" rowspan="1" colspan="1">3.1 (0.8–7.9)</td>
<td align="left" rowspan="1" colspan="1">2.6 (0.5–9.6)</td>
<td align="left" rowspan="1" colspan="1">0.241</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Median follow-up of survivors, days (range)</td>
<td align="left" rowspan="1" colspan="1">716 (7–2562)</td>
<td align="left" rowspan="1" colspan="1">1506 (99–2632)</td>
<td align="left" rowspan="1" colspan="1">0.128</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/j_jtim-2025-0032_tab_003/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p"><div class="fn" id="j_jtim-2025-0032_tfn_102"><p>Allo-HSCT: allogeneic hematopoietic stem cell transplantation; CR: complete remission; HLA: human leukocyte antigen; HCT-CI: hematopoietic cell transplantation-specific comorbidity index; TBI: total body irradiation; MNC: mononuclear cell; ELN: European LeukaemiaNet.</p></div></div></section><figure class="fig xbox font-sm" id="j_jtim-2025-0032_fig_003"><h4 class="obj_head">Figure 3.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12371398_j_jtim-2025-0032_fig_003.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7dbd/12371398/cb37ace0f236/j_jtim-2025-0032_fig_003.jpg" loading="lazy" height="439" width="625" alt="Figure 3"></a></p>
<div class="p text-right font-secondary"><a href="figure/j_jtim-2025-0032_fig_003/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>The 2-year probability of clinical outcomes after allo-HSCT according to patients with and without <em>DEK-NUP214</em> transcript, relapse (A), non-relapse mortality (B), leukaemia-free survival (C), and overall survival (D).</p></figcaption></figure></section></section><section id="j_jtim-2025-0032_s_006"><h2 class="pmc_sec_title">Discussion</h2>
<p>Owing to the rarity of AML in patients with <em>DEK-NUP214</em>, multicenter cooperative efforts are required to analyze the specific outcomes and the results of allo-HSCT. In the present study, we observed that the 2-year probabilities of relapse, NRM, LFS, and OS after allo-HSCT were 14.3%, 35.7%, 50.0%, and 50.0%, respectively, in AML patients with <em>DEK-NUP214</em> transcripts. In particular, we observed that more than 75% of patients achieved MRD negativity after allo-HSCT and that pretransplant <em>DEK-NUP214</em> positivity did not influence posttransplant outcomes. To our knowledge, this is the first and largest study focusing on the dynamic evolution of <em>DEK-NUP214</em> positivity before and after allo-HSCT in patients with AML and <em>DEK-NUP214</em> fusion.</p>
<p>Garcon <em>et al</em>.<sup>[<a href="#j_jtim-2025-0032_ref_005" class="usa-link" aria-describedby="j_jtim-2025-0032_ref_005">5</a>]</sup> reported that patients with AML with t(6;9) (p23;q34) who achieved consistent molecular remission, as assessed by real-time quantitative polymerase chain reaction (PCR), showed better survival than patients with persistent <em>DEK-NUP214</em> positivity, implying a pivotal role for MRD monitoring in this AML subtype. In particular, they observed that all patients with persistent <em>DEK-NUP214</em> positivity after chemotherapy died of refractory disease, except for one patient who died of toxicity.<sup>[<a href="#j_jtim-2025-0032_ref_005" class="usa-link" aria-describedby="j_jtim-2025-0032_ref_005">5</a>]</sup> In contrast, in the present study, we observed that most patients achieved MRD negativity after allo-HSCT, suggesting that allo-HSCT could overcome the poor prognosis of persistent <em>DEK-NUP214</em> positivity after chemotherapy. This may be attributed to the graft-versus-leukemia (GVL) effect.<sup>[<a href="#j_jtim-2025-0032_ref_026" class="usa-link" aria-describedby="j_jtim-2025-0032_ref_026">26</a>]</sup> In addition, several studies have reported that allo-HSCT, particularly HID HSCT, could overcome the negative impact of pretransplant MRD positivity on posttransplant outcomes.<sup>[<a href="#j_jtim-2025-0032_ref_027" class="usa-link" aria-describedby="j_jtim-2025-0032_ref_027">27</a>, <a href="#j_jtim-2025-0032_ref_028" class="usa-link" aria-describedby="j_jtim-2025-0032_ref_028">28</a>, <a href="#j_jtim-2025-0032_ref_029" class="usa-link" aria-describedby="j_jtim-2025-0032_ref_029">29</a>, <a href="#j_jtim-2025-0032_ref_030" class="usa-link" aria-describedby="j_jtim-2025-0032_ref_030">30</a>]</sup> In the present study, nearly 85% of the patients underwent HID HSCT, which may have also contributed to the high conversion of MRD positivity to negativity.</p>
<p>We observed that the 2-year cumulative incidence of relapse after allo-HSCT was only 14.3% in AML patients with <em>DEK-NUP214</em>, which was comparable to that in intermediate- or high-risk AML patients without <em>DEK-NUP214</em>. Previous studies showed that the relapse rate of AML patients with <em>DEK-NUP214</em> was &gt; 80% and the 5-year survival rate was only 9% for those who did not receive allo-HSCT.<sup>[<a href="#j_jtim-2025-0032_ref_002" class="usa-link" aria-describedby="j_jtim-2025-0032_ref_002">2</a>,<a href="#j_jtim-2025-0032_ref_031" class="usa-link" aria-describedby="j_jtim-2025-0032_ref_031">31</a>]</sup> Wang <em>et al</em>.<sup>[<a href="#j_jtim-2025-0032_ref_032" class="usa-link" aria-describedby="j_jtim-2025-0032_ref_032">32</a>]</sup> reported that the incidence of relapse was approximately 16% in adult patients with AML receiving allo-HSCT at CR1. Thus, allo-HSCT can overcome the effect of <em>DEK-NUP214</em> on relapse in patients with AML. However, the 2-year cumulative incidence of NRM in <em>the DEK-NUP214</em> group was 35.7%, which was higher than that in the group without <em>DEK-NUP214</em>. In previous studies, the cumulative incidence of NRM in HID HSCT was 11.6%–34.0%.<sup>[<a href="#j_jtim-2025-0032_ref_028" class="usa-link" aria-describedby="j_jtim-2025-0032_ref_028">28</a>,<a href="#j_jtim-2025-0032_ref_033" class="usa-link" aria-describedby="j_jtim-2025-0032_ref_033">33</a>,<a href="#j_jtim-2025-0032_ref_034" class="usa-link" aria-describedby="j_jtim-2025-0032_ref_034">34</a>,<a href="#j_jtim-2025-0032_ref_035" class="usa-link" aria-describedby="j_jtim-2025-0032_ref_035">35</a>]</sup> Considering that most patients received HID HSCT in the present study and the bias in the small sample size, our NRM incidence was not significantly higher than that in those who enrolled HID HSCT recipients. On the other hand, we found that the DEK-NUP214 group had a higher ELN risk (<em>P</em> = 0.001). Therefore, we believe it is possible that the high NRM incidence is associated with a high ELN risk baseline in the DEK-NUP214 group.</p>
<p>Our cohort showed that concomitant <em>FLT3</em>-ITD mutations were present in 28.5% of patients in the present cohort, which is lower than the results of previous studies by Oyarzo <em>et al</em>.<sup>[<a href="#j_jtim-2025-0032_ref_036" class="usa-link" aria-describedby="j_jtim-2025-0032_ref_036">36</a>]</sup> This may also contribute to the fact that only 3 patients received <em>FLT3</em> inhibitors as maintenance therapy in our study. Although concomitant <em>FLT3</em>-ITD mutations may provide a therapeutic target, it is unclear whether <em>FLT3</em> inhibitor maintenance therapy provides a survival benefit in AML patients with <em>DEK-NUP214</em> transcripts after allo-HSCT.<sup>[<a href="#j_jtim-2025-0032_ref_037" class="usa-link" aria-describedby="j_jtim-2025-0032_ref_037">37</a>]</sup> In our study, one patient still relapsed despite the use of sorafenib as maintenance therapy. In a large cohort study of adult AML patients with <em>DEK-NUP214</em>, seven patients who had relapsed either after allo-HSCT or post-chemotherapy were treated with TKIs in isolation or in combination with chemotherapy, which failed to achieve a response in the majority of patients.<sup>[<a href="#j_jtim-2025-0032_ref_031" class="usa-link" aria-describedby="j_jtim-2025-0032_ref_031">31</a>]</sup> These findings suggest that novel treatment strategies are needed to improve patient outcomes. Because <em>NUP214</em> is part of the nuclear pore complex and is a critical player in the nuclear export of proteins and mRNA, several inhibitors of nuclear export proteins, such as CRM1 and XPO1, may have potential therapeutic effects in patients with AML and <em>DEK-NUP214</em> fusion.<sup>[<a href="#j_jtim-2025-0032_ref_038" class="usa-link" aria-describedby="j_jtim-2025-0032_ref_038">38</a>,<a href="#j_jtim-2025-0032_ref_039" class="usa-link" aria-describedby="j_jtim-2025-0032_ref_039">39</a>]</sup></p>
<p>The maintenance of sorafenib therapy after allo-HSCT could further decrease the incidence of relapse and improve LFS<sup>[<a href="#j_jtim-2025-0032_ref_040" class="usa-link" aria-describedby="j_jtim-2025-0032_ref_040">40</a>,<a href="#j_jtim-2025-0032_ref_041" class="usa-link" aria-describedby="j_jtim-2025-0032_ref_041">41</a>]</sup> of AML patients with FLT3 mutation; however, Xuan <em>et al</em>.<sup>[<a href="#j_jtim-2025-0032_ref_040" class="usa-link" aria-describedby="j_jtim-2025-0032_ref_040">40</a>]</sup> reported that male patients who were MRD positivity before or after allo-HSCT could benefit from sorafenib maintenance therapy. Similarly, in MORPHO study,<sup>[<a href="#j_jtim-2025-0032_ref_042" class="usa-link" aria-describedby="j_jtim-2025-0032_ref_042">42</a>]</sup> the researchers also observed that the benefits of gilteritinib maintenance was restricted in patients with MRD positivity before allo-HSCT. Thus, the efficacy of FLT3 inhibitor maintenance for patients who were MRD negativity before allo-HSCT should be further identified. Lastly, patients received MRD monitoring regularly after allo-HSCT. Thus, patients who had positive MRD received preemptive therapy in the present study, which might help to prevent relapse in those without maintenance therapies.</p>
<p>This study had some limitations. Firstly, it was a retrospective study. In addition, due to the small sample size, some trends did not reach statistical significance. Further prospective studies or larger multicentre retrospective studies are needed to confirm and supplement our present study findings.</p>
<p>In summary, our study demonstrated that allo-HSCT can overcome the poor prognosis associated with persistent <em>DEK-NUP214</em> positivity after chemotherapy in patients with AML. However, the posttransplant outcomes of AML patients with <em>DEK-NUP214</em> transcripts were poorer than those of patients without <em>DEK-NUP214</em> transcript. Future studies should identify better therapeutic strategies to improve the clinical outcomes of <em>DEK-NUP214</em> subtype in AML.</p></section><section id="j_jtim-2025-0032_ack_001" class="ack"><h2 class="pmc_sec_title">Acknowledgements</h2>
<p>None.</p></section><section id="funding-statement1" lang="en"><h2 class="pmc_sec_title">Funding Statement</h2>
<p>This work was supported by the National Key Research and Development Program of China (2022YFC2502600, 2022YFC2502606, 2021YFA1101503), the National Natural Science Foundation of China (82170206, 82170208 and 81973998), CAMS Innovation Fund for Medical Sciences (2019-I2M-5-034, 2022-I2M-C&amp;T-B-121), Peking University People’s Hospital Research and Development Funds (RZ2022-02), National High Level Hospital Clinical Research Funding (BJ-2022-169), and Shanghai Municipal Health Commission Project of Disciplines of Excellence (20234Z0002).</p></section><section id="fn-group1" class="fn-group"><h2 class="pmc_sec_title">Footnotes</h2>
<div class="fn-group p font-secondary-light font-sm">
<div class="fn p" id="j_jtim-2025-0032_fn_102">
<p>
<strong>Author Contributions</strong>
</p>
<p>Mo XD and Hu XX designed the protocol; Fan S, Yang Y and Lu SY wrote the manuscript. Fan S and Yang Y performed the analysis; all authors contributed patients and provided clinical and laboratory data; all authors revised, corrected, and approved the manuscript. Fan S, Yang Y and Lu SY contributed equally to this manuscript.</p>
</div>
<div class="fn p" id="j_jtim-2025-0032_fn_103">
<p>
<strong>Ethical Approval</strong>
</p>
<p>This is a retrospective study. The study was conducted in accordance with the Declaration of Helsinki as well as the relevant guidelines and regulations.</p>
</div>
<div class="fn p" id="j_jtim-2025-0032_fn_104">
<p>
<strong>Informed Consent</strong>
</p>
<p>The need for informed consent was waived by IRB of Peking University People’s Hospital, Wuhan Tongji Hospital and Shanghai RuiJin Hospital because of the retrospective nature of the study.</p>
</div>
<div class="fn p" id="j_jtim-2025-0032_fn_105">
<p>
<strong>Conflict of Interest</strong>
</p>
<p>The authors declare no competing interests.</p>
</div>
<div class="fn p" id="j_jtim-2025-0032_fn_106">
<p>
<strong>Use of Large Language Models, AI and Machine Learning Tools</strong>
</p>
<p>None declared.</p>
</div>
<div class="fn p" id="j_jtim-2025-0032_fn_107">
<p>
<strong>Data Availability Statement</strong>
</p>
<p>The datasets generated during the analysis of the current study are available from the corresponding author on reasonable request.</p>
</div>
</div></section><section id="_ci93_" lang="en" class="contrib-info"><h2 class="pmc_sec_title">Contributor Information</h2>
<p>Xiaodong Mo, Email: moxiaodong@bjmu.edu.cn.</p>
<p>Xiaoxia Hu, Email: hxx12276@rjh.com.cn.</p></section><section id="ref-list1" class="ref-list"><h2 class="pmc_sec_title">References</h2>
<section id="ref-list1_sec2"><ul class="ref-list font-sm" style="list-style-type:none">
<li id="j_jtim-2025-0032_ref_001">
<span class="label">1.</span><cite>Vardiman JW, Thiele J, Arber DA, Brunning RD, Borowitz MJ, Porwit A. The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes. Blood. 2009;114:937. doi: 10.1182/blood-2009-03-209262. et al. -</cite> [<a href="https://doi.org/10.1182/blood-2009-03-209262" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19357394/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Blood&amp;title=The%202008%20revision%20of%20the%20World%20Health%20Organization%20(WHO)%20classification%20of%20myeloid%20neoplasms%20and%20acute%20leukemia:%20rationale%20and%20important%20changes&amp;author=JW%20Vardiman&amp;author=J%20Thiele&amp;author=DA%20Arber&amp;author=RD%20Brunning&amp;author=MJ%20Borowitz&amp;volume=114&amp;publication_year=2009&amp;pages=937-951&amp;pmid=19357394&amp;doi=10.1182/blood-2009-03-209262&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="j_jtim-2025-0032_ref_002">
<span class="label">2.</span><cite>Slovak ML, Gundacker H, Bloomfield CD, Dewald G, Appelbaum FR, Larson RA. A retrospective study of 69 patients with t(6;9)(p23;q34) AML emphasizes the need for a prospective, multicenter initiative for rare ‘poor prognosis’ myeloid malignancies. Leukemia. 2006;20:1295. doi: 10.1038/sj.leu.2404233. et al. -</cite> [<a href="https://doi.org/10.1038/sj.leu.2404233" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/16628187/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Leukemia&amp;title=A%20retrospective%20study%20of%2069%20patients%20with%20t(6;9)(p23;q34)%20AML%20emphasizes%20the%20need%20for%20a%20prospective,%20multicenter%20initiative%20for%20rare%20%E2%80%98poor%20prognosis%E2%80%99%20myeloid%20malignancies&amp;author=ML%20Slovak&amp;author=H%20Gundacker&amp;author=CD%20Bloomfield&amp;author=G%20Dewald&amp;author=FR%20Appelbaum&amp;volume=20&amp;publication_year=2006&amp;pages=1295-1297&amp;pmid=16628187&amp;doi=10.1038/sj.leu.2404233&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="j_jtim-2025-0032_ref_003">
<span class="label">3.</span><cite>Grimwade D, Hills RK, Moorman AV, Walker H, Chatters S, Goldstone AH. Refinement of cytogenetic classification in acute myeloid leukemia: determination of prognostic significance of rare recurring chromosomal abnormalities among 5876 younger adult patients treated in the United Kingdom Medical Research Council trials. Blood. 2010;116:354. doi: 10.1182/blood-2009-11-254441. et al. -</cite> [<a href="https://doi.org/10.1182/blood-2009-11-254441" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20385793/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Blood&amp;title=Refinement%20of%20cytogenetic%20classification%20in%20acute%20myeloid%20leukemia:%20determination%20of%20prognostic%20significance%20of%20rare%20recurring%20chromosomal%20abnormalities%20among%205876%20younger%20adult%20patients%20treated%20in%20the%20United%20Kingdom%20Medical%20Research%20Council%20trials&amp;author=D%20Grimwade&amp;author=RK%20Hills&amp;author=AV%20Moorman&amp;author=H%20Walker&amp;author=S%20Chatters&amp;volume=116&amp;publication_year=2010&amp;pages=354-365&amp;pmid=20385793&amp;doi=10.1182/blood-2009-11-254441&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="j_jtim-2025-0032_ref_004">
<span class="label">4.</span><cite>Tarlock K, Alonzo TA, Moraleda PP, Gerbing RB, Raimondi SC, Hirsch BA. Acute myeloid leukaemia (AML) with t(6;9)(p23;q34) is associated with poor outcome in childhood AML regardless of FLT3-ITD status: a report from the Children’s Oncology Group. Br J Haematol. 2014;166:254. doi: 10.1111/bjh.12852. et al. -</cite> [<a href="https://doi.org/10.1111/bjh.12852" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4079767/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24661089/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Br%20J%20Haematol&amp;title=Acute%20myeloid%20leukaemia%20(AML)%20with%20t(6;9)(p23;q34)%20is%20associated%20with%20poor%20outcome%20in%20childhood%20AML%20regardless%20of%20FLT3-ITD%20status:%20a%20report%20from%20the%20Children%E2%80%99s%20Oncology%20Group&amp;author=K%20Tarlock&amp;author=TA%20Alonzo&amp;author=PP%20Moraleda&amp;author=RB%20Gerbing&amp;author=SC%20Raimondi&amp;volume=166&amp;publication_year=2014&amp;pages=254-259&amp;pmid=24661089&amp;doi=10.1111/bjh.12852&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="j_jtim-2025-0032_ref_005">
<span class="label">5.</span><cite>Garçon L, Libura M, Delabesse E, Valensi F, Asnafi V, Berger C. DEK-CAN molecular monitoring of myeloid malignancies could aid therapeutic stratification. Leukemia. 2005;19:1338. doi: 10.1038/sj.leu.2403835. et al. -</cite> [<a href="https://doi.org/10.1038/sj.leu.2403835" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/15973457/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Leukemia&amp;title=DEK-CAN%20molecular%20monitoring%20of%20myeloid%20malignancies%20could%20aid%20therapeutic%20stratification&amp;author=L%20Gar%C3%A7on&amp;author=M%20Libura&amp;author=E%20Delabesse&amp;author=F%20Valensi&amp;author=V%20Asnafi&amp;volume=19&amp;publication_year=2005&amp;pages=1338-1344&amp;pmid=15973457&amp;doi=10.1038/sj.leu.2403835&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="j_jtim-2025-0032_ref_006">
<span class="label">6.</span><cite>Wang L, Zhang C, Fan S, Mo X, Hu X. Treatment options for adult intermediate-risk AML patients in CR1: Allo-HSCT or chemotherapy? Innovation (Camb) 2023;4:100461. doi: 10.1016/j.xinn.2023.100461.</cite> [<a href="https://doi.org/10.1016/j.xinn.2023.100461" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10336665/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37448742/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Innovation%20(Camb)&amp;title=Treatment%20options%20for%20adult%20intermediate-risk%20AML%20patients%20in%20CR1:%20Allo-HSCT%20or%20chemotherapy?&amp;author=L%20Wang&amp;author=C%20Zhang&amp;author=S%20Fan&amp;author=X%20Mo&amp;author=X%20Hu&amp;volume=4&amp;publication_year=2023&amp;pages=100461&amp;pmid=37448742&amp;doi=10.1016/j.xinn.2023.100461&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="j_jtim-2025-0032_ref_007">
<span class="label">7.</span><cite>Cao Y, Zhang C, Cao L, Mo X, Hu X. Quizartinib is a good option for AML patients with FLT3-ITD mutations. TIME. 2023;1:100007.</cite> [<a href="https://scholar.google.com/scholar_lookup?journal=TIME&amp;title=Quizartinib%20is%20a%20good%20option%20for%20AML%20patients%20with%20FLT3-ITD%20mutations&amp;author=Y%20Cao&amp;author=C%20Zhang&amp;author=L%20Cao&amp;author=X%20Mo&amp;author=X%20Hu&amp;volume=1&amp;publication_year=2023&amp;pages=100007&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="j_jtim-2025-0032_ref_008">
<span class="label">8.</span><cite>Ishiyama K, Takami A, Kanda Y, Nakao S, Hidaka M, Maeda T. Prognostic factors for acute myeloid leukemia patients with t(6;9) (p23;q34) who underwent an allogeneic hematopoietic stem cell transplant. Leukemia. 2012;26:1416. doi: 10.1038/leu.2011.350. et al. -</cite> [<a href="https://doi.org/10.1038/leu.2011.350" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22157737/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Leukemia&amp;title=Prognostic%20factors%20for%20acute%20myeloid%20leukemia%20patients%20with%20t(6;9)%20(p23;q34)%20who%20underwent%20an%20allogeneic%20hematopoietic%20stem%20cell%20transplant&amp;author=K%20Ishiyama&amp;author=A%20Takami&amp;author=Y%20Kanda&amp;author=S%20Nakao&amp;author=M%20Hidaka&amp;volume=26&amp;publication_year=2012&amp;pages=1416-1419&amp;pmid=22157737&amp;doi=10.1038/leu.2011.350&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="j_jtim-2025-0032_ref_009">
<span class="label">9.</span><cite>Ishiyama K, Takami A, Kanda Y, Nakao S, Hidaka M, Maeda T. Allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia with t(6;9)(p23;q34) dramatically improves the patient prognosis: a matched-pair analysis. Leukemia. 2012;26:461. doi: 10.1038/leu.2011.229. et al. -</cite> [<a href="https://doi.org/10.1038/leu.2011.229" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21869835/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Leukemia&amp;title=Allogeneic%20hematopoietic%20stem%20cell%20transplantation%20for%20acute%20myeloid%20leukemia%20with%20t(6;9)(p23;q34)%20dramatically%20improves%20the%20patient%20prognosis:%20a%20matched-pair%20analysis&amp;author=K%20Ishiyama&amp;author=A%20Takami&amp;author=Y%20Kanda&amp;author=S%20Nakao&amp;author=M%20Hidaka&amp;volume=26&amp;publication_year=2012&amp;pages=461-464&amp;pmid=21869835&amp;doi=10.1038/leu.2011.229&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="j_jtim-2025-0032_ref_010">
<span class="label">10.</span><cite>Díaz-Beyá M, Labopin M, Maertens J, Aljurf M, Passweg J, Dietrich B. Allogeneic stem cell transplantation in AML with t(6;9) (p23;q34);DEK-NUP214 shows a favourable outcome when performed in first complete remission. Br J Haematol. 2020;189:920. doi: 10.1111/bjh.16433. et al. -</cite> [<a href="https://doi.org/10.1111/bjh.16433" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32020596/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Br%20J%20Haematol&amp;title=Allogeneic%20stem%20cell%20transplantation%20in%20AML%20with%20t(6;9)%20(p23;q34);DEK-NUP214%20shows%20a%20favourable%20outcome%20when%20performed%20in%20first%20complete%20remission&amp;author=M%20D%C3%ADaz-Bey%C3%A1&amp;author=M%20Labopin&amp;author=J%20Maertens&amp;author=M%20Aljurf&amp;author=J%20Passweg&amp;volume=189&amp;publication_year=2020&amp;pages=920-925&amp;pmid=32020596&amp;doi=10.1111/bjh.16433&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="j_jtim-2025-0032_ref_011">
<span class="label">11.</span><cite>Mrózek K, Marcucci G, Nicolet D, Maharry KS, Becker H, Whitman SP. Prognostic significance of the European LeukemiaNet standardized system for reporting cytogenetic and molecular alterations in adults with acute myeloid leukemia. J Clin Oncol. 2012;30:4515. doi: 10.1200/JCO.2012.43.4738. et al. -</cite> [<a href="https://doi.org/10.1200/JCO.2012.43.4738" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3518729/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22987078/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Clin%20Oncol&amp;title=Prognostic%20significance%20of%20the%20European%20LeukemiaNet%20standardized%20system%20for%20reporting%20cytogenetic%20and%20molecular%20alterations%20in%20adults%20with%20acute%20myeloid%20leukemia&amp;author=K%20Mr%C3%B3zek&amp;author=G%20Marcucci&amp;author=D%20Nicolet&amp;author=KS%20Maharry&amp;author=H%20Becker&amp;volume=30&amp;publication_year=2012&amp;pages=4515-4523&amp;pmid=22987078&amp;doi=10.1200/JCO.2012.43.4738&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="j_jtim-2025-0032_ref_012">
<span class="label">12.</span><cite>Cao Y, Huo W, Huang J, Yang Y, Wang Y, Chang Y. MRD positivity was the poor prognostic factor for adverse-risk AML patients with allogeneic hematopoietic stem cell transplantation: a multicenter TROPHY study. Blood Cancer J. 2024;14:8. doi: 10.1038/s41408-024-00976-1. et al.</cite> [<a href="https://doi.org/10.1038/s41408-024-00976-1" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10791633/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38228581/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Blood%20Cancer%20J&amp;title=MRD%20positivity%20was%20the%20poor%20prognostic%20factor%20for%20adverse-risk%20AML%20patients%20with%20allogeneic%20hematopoietic%20stem%20cell%20transplantation:%20a%20multicenter%20TROPHY%20study&amp;author=Y%20Cao&amp;author=W%20Huo&amp;author=J%20Huang&amp;author=Y%20Yang&amp;author=Y%20Wang&amp;volume=14&amp;publication_year=2024&amp;pages=8&amp;pmid=38228581&amp;doi=10.1038/s41408-024-00976-1&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="j_jtim-2025-0032_ref_013">
<span class="label">13.</span><cite>Shen MZ, Hong SD, Lou R, Chen RZ, Zhang XH, Xu LP. A comprehensive model to predict severe acute graft-versus-host disease in acute leukemia patients after haploidentical hematopoietic stem cell transplantation. Exp Hematol Oncol. 2022;11:25. doi: 10.1186/s40164-022-00278-x. et al.</cite> [<a href="https://doi.org/10.1186/s40164-022-00278-x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9067003/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35505384/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Exp%20Hematol%20Oncol&amp;title=A%20comprehensive%20model%20to%20predict%20severe%20acute%20graft-versus-host%20disease%20in%20acute%20leukemia%20patients%20after%20haploidentical%20hematopoietic%20stem%20cell%20transplantation&amp;author=MZ%20Shen&amp;author=SD%20Hong&amp;author=R%20Lou&amp;author=RZ%20Chen&amp;author=XH%20Zhang&amp;volume=11&amp;publication_year=2022&amp;pages=25&amp;pmid=35505384&amp;doi=10.1186/s40164-022-00278-x&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="j_jtim-2025-0032_ref_014">
<span class="label">14.</span><cite>Shen MZ, Hong SD, Wang J, Zhang XH, Xu LP, Wang Y. A Predicted Model for Refractory/Recurrent Cytomegalovirus Infection in Acute Leukemia Patients After Haploidentical Hematopoietic Stem Cell Transplantation. Front Cell Infect Microbiol. 2022;12:862526. doi: 10.3389/fcimb.2022.862526. et al.</cite> [<a href="https://doi.org/10.3389/fcimb.2022.862526" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8981086/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35392613/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Front%20Cell%20Infect%20Microbiol&amp;title=A%20Predicted%20Model%20for%20Refractory/Recurrent%20Cytomegalovirus%20Infection%20in%20Acute%20Leukemia%20Patients%20After%20Haploidentical%20Hematopoietic%20Stem%20Cell%20Transplantation&amp;author=MZ%20Shen&amp;author=SD%20Hong&amp;author=J%20Wang&amp;author=XH%20Zhang&amp;author=LP%20Xu&amp;volume=12&amp;publication_year=2022&amp;pages=862526&amp;pmid=35392613&amp;doi=10.3389/fcimb.2022.862526&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="j_jtim-2025-0032_ref_015">
<span class="label">15.</span><cite>Fan S, Hong HY, Dong XY, Xu LP, Zhang XH, Wang Y. Machine learning algorithm as a prognostic tool for Epstein-Barr virus reactivation after haploidentical hematopoietic stem cell transplantation. Blood Sci. 2023;5:51. doi: 10.1097/BS9.0000000000000143. et al. -</cite> [<a href="https://doi.org/10.1097/BS9.0000000000000143" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9891443/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36742189/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Blood%20Sci&amp;title=Machine%20learning%20algorithm%20as%20a%20prognostic%20tool%20for%20Epstein-Barr%20virus%20reactivation%20after%20haploidentical%20hematopoietic%20stem%20cell%20transplantation&amp;author=S%20Fan&amp;author=HY%20Hong&amp;author=XY%20Dong&amp;author=LP%20Xu&amp;author=XH%20Zhang&amp;volume=5&amp;publication_year=2023&amp;pages=51-59&amp;pmid=36742189&amp;doi=10.1097/BS9.0000000000000143&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="j_jtim-2025-0032_ref_016">
<span class="label">16.</span><cite>Deng DX, Fan S, Zhang XH, Xu LP, Wang Y, Yan CH. Immune Reconstitution of Patients Who Recovered From Steroid-Refractory Acute Graft-Versus-Host Disease After Basiliximab Treatment. Front Oncol. 2022;12:916442. doi: 10.3389/fonc.2022.916442. et al.</cite> [<a href="https://doi.org/10.3389/fonc.2022.916442" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9351448/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35936697/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Front%20Oncol&amp;title=Immune%20Reconstitution%20of%20Patients%20Who%20Recovered%20From%20Steroid-Refractory%20Acute%20Graft-Versus-Host%20Disease%20After%20Basiliximab%20Treatment&amp;author=DX%20Deng&amp;author=S%20Fan&amp;author=XH%20Zhang&amp;author=LP%20Xu&amp;author=Y%20Wang&amp;volume=12&amp;publication_year=2022&amp;pages=916442&amp;pmid=35936697&amp;doi=10.3389/fonc.2022.916442&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="j_jtim-2025-0032_ref_017">
<span class="label">17.</span><cite>Deng D, Shen M, Zhang X, Xu L, Wang Y, Yan C. Basiliximab is the potential solution for severe liver chronic GVHD: A prospective pilot study. TIME. 2023;1:100009. et al.</cite> [<a href="https://scholar.google.com/scholar_lookup?journal=TIME&amp;title=Basiliximab%20is%20the%20potential%20solution%20for%20severe%20liver%20chronic%20GVHD:%20A%20prospective%20pilot%20study&amp;author=D%20Deng&amp;author=M%20Shen&amp;author=X%20Zhang&amp;author=L%20Xu&amp;author=Y%20Wang&amp;volume=1&amp;publication_year=2023&amp;pages=100009&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="j_jtim-2025-0032_ref_018">
<span class="label">18.</span><cite>Xu Z, Mo X, Kong Y, Wen Q, Han T, Lyu M. Mini-dose methotrexate combined with methylprednisolone as a first-line treatment for acute graft-versus-host disease: A phase 2 trial. J Transl Int Med. 2023;11:255. doi: 10.2478/jtim-2023-0111. et al. -</cite> [<a href="https://doi.org/10.2478/jtim-2023-0111" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10474881/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37662885/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Transl%20Int%20Med&amp;title=Mini-dose%20methotrexate%20combined%20with%20methylprednisolone%20as%20a%20first-line%20treatment%20for%20acute%20graft-versus-host%20disease:%20A%20phase%202%20trial&amp;author=Z%20Xu&amp;author=X%20Mo&amp;author=Y%20Kong&amp;author=Q%20Wen&amp;author=T%20Han&amp;volume=11&amp;publication_year=2023&amp;pages=255-264&amp;pmid=37662885&amp;doi=10.2478/jtim-2023-0111&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="j_jtim-2025-0032_ref_019">
<span class="label">19.</span><cite>Liu Y, Duan W, Huang X, Lu J. A first case report of using chimeric antigen receptor T-cell immunotherapy to treat high-risk smoldering multiple myeloma. J Transl Int Med. 2023;11:294. doi: 10.2478/jtim-2023-0097. -</cite> [<a href="https://doi.org/10.2478/jtim-2023-0097" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10474885/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37662884/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Transl%20Int%20Med&amp;title=A%20first%20case%20report%20of%20using%20chimeric%20antigen%20receptor%20T-cell%20immunotherapy%20to%20treat%20high-risk%20smoldering%20multiple%20myeloma&amp;author=Y%20Liu&amp;author=W%20Duan&amp;author=X%20Huang&amp;author=J%20Lu&amp;volume=11&amp;publication_year=2023&amp;pages=294-296&amp;pmid=37662884&amp;doi=10.2478/jtim-2023-0097&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="j_jtim-2025-0032_ref_020">
<span class="label">20.</span><cite>Wang Y, Chen H, Chen J, Han M, Hu J, Huang H. The consensus on the monitoring, treatment, and prevention of leukemia relapse after allogeneic hematopoietic stem cell transplantation in China. Cancer Lett. 2018;438:63. doi: 10.1016/j.canlet.2018.08.030. et al. -</cite> [<a href="https://doi.org/10.1016/j.canlet.2018.08.030" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30217562/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cancer%20Lett&amp;title=The%20consensus%20on%20the%20monitoring,%20treatment,%20and%20prevention%20of%20leukemia%20relapse%20after%20allogeneic%20hematopoietic%20stem%20cell%20transplantation%20in%20China&amp;author=Y%20Wang&amp;author=H%20Chen&amp;author=J%20Chen&amp;author=M%20Han&amp;author=J%20Hu&amp;volume=438&amp;publication_year=2018&amp;pages=63-75&amp;pmid=30217562&amp;doi=10.1016/j.canlet.2018.08.030&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="j_jtim-2025-0032_ref_021">
<span class="label">21.</span><cite>Laboratory Diagnosis Group, Chinese Society of Hematology, Chinese Medical Association Chinese consensus on minimal residual disease detection and interpretation of patients with acute myeloid leukemia. Zhonghua Xueyexue Zazhi. 2021;42:889. doi: 10.3760/cma.j.issn.0253-2727.2021.11.002. -</cite> [<a href="https://doi.org/10.3760/cma.j.issn.0253-2727.2021.11.002" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8763587/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35045649/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Zhonghua%20Xueyexue%20Zazhi&amp;title=Laboratory%20Diagnosis%20Group,%20Chinese%20Society%20of%20Hematology,%20Chinese%20Medical%20Association%20Chinese%20consensus%20on%20minimal%20residual%20disease%20detection%20and%20interpretation%20of%20patients%20with%20acute%20myeloid%20leukemia&amp;volume=42&amp;publication_year=2021&amp;pages=889-97&amp;pmid=35045649&amp;doi=10.3760/cma.j.issn.0253-2727.2021.11.002&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="j_jtim-2025-0032_ref_022">
<span class="label">22.</span><cite>Chinese Society of Hematology, Chinese Medical Association The consensus of allogeneic hematopoietic transplantation for hematological diseases in China (2016)-- post- transplant leukemia relapse. Zhonghua Xueyexue Zazhi. 2016;37:846. doi: 10.3760/cma.j.issn.0253-2727.2016.10.004. -</cite> [<a href="https://doi.org/10.3760/cma.j.issn.0253-2727.2016.10.004" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7364870/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27801312/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Zhonghua%20Xueyexue%20Zazhi&amp;title=Chinese%20Society%20of%20Hematology,%20Chinese%20Medical%20Association%20The%20consensus%20of%20allogeneic%20hematopoietic%20transplantation%20for%20hematological%20diseases%20in%20China%20(2016)--%20post-%20transplant%20leukemia%20relapse&amp;volume=37&amp;publication_year=2016&amp;pages=846-51&amp;pmid=27801312&amp;doi=10.3760/cma.j.issn.0253-2727.2016.10.004&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="j_jtim-2025-0032_ref_023">
<span class="label">23.</span><cite>Gao MG, Fu Q, Qin YZ, Chang YJ, Wang Y, Yan CH. Prognostic significance of DEK-NUP214 fusion gene in patients with acute myeloid leukemia after allogeneic hematopoietic stem cell transplantation. Zhonghua Neike Zazhi. 2021;60(10):868. doi: 10.3760/cma.j.cn112138-20201015-00868. et al. -</cite> [<a href="https://doi.org/10.3760/cma.j.cn112138-20201015-00868" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34551474/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Zhonghua%20Neike%20Zazhi&amp;title=Prognostic%20significance%20of%20DEK-NUP214%20fusion%20gene%20in%20patients%20with%20acute%20myeloid%20leukemia%20after%20allogeneic%20hematopoietic%20stem%20cell%20transplantation&amp;author=MG%20Gao&amp;author=Q%20Fu&amp;author=YZ%20Qin&amp;author=YJ%20Chang&amp;author=Y%20Wang&amp;volume=60&amp;issue=10&amp;publication_year=2021&amp;pages=868-74&amp;pmid=34551474&amp;doi=10.3760/cma.j.cn112138-20201015-00868&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="j_jtim-2025-0032_ref_024">
<span class="label">24.</span><cite>Liu J, Ma R, Liu YR, Xu LP, Zhang XH, Chen H. The significance of peri-transplantation minimal residual disease assessed by multiparameter flow cytometry on outcomes for adult AML patients receiving haploidentical allografts. Bone Marrow Transplant. 2019;54:567. doi: 10.1038/s41409-018-0300-8. et al. -</cite> [<a href="https://doi.org/10.1038/s41409-018-0300-8" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30127465/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Bone%20Marrow%20Transplant&amp;title=The%20significance%20of%20peri-transplantation%20minimal%20residual%20disease%20assessed%20by%20multiparameter%20flow%20cytometry%20on%20outcomes%20for%20adult%20AML%20patients%20receiving%20haploidentical%20allografts&amp;author=J%20Liu&amp;author=R%20Ma&amp;author=YR%20Liu&amp;author=LP%20Xu&amp;author=XH%20Zhang&amp;volume=54&amp;publication_year=2019&amp;pages=567-577&amp;pmid=30127465&amp;doi=10.1038/s41409-018-0300-8&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="j_jtim-2025-0032_ref_025">
<span class="label">25.</span><cite>Gooley TA, Leisenring W, Crowley J, Storer BE. Estimation of failure probabilities in the presence of competing risks: new representations of old estimators. Statist Med. 1999;18:695. doi: 10.1002/(sici)1097-0258(19990330)18:6&lt;695::aid-sim60&gt;3.0.co;2-o. -</cite> [<a href="https://doi.org/10.1002/(sici)1097-0258(19990330)18:6&lt;695::aid-sim60&gt;3.0.co;2-o" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/10204198/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Statist%20Med&amp;title=Estimation%20of%20failure%20probabilities%20in%20the%20presence%20of%20competing%20risks:%20new%20representations%20of%20old%20estimators&amp;author=TA%20Gooley&amp;author=W%20Leisenring&amp;author=J%20Crowley&amp;author=BE%20Storer&amp;volume=18&amp;publication_year=1999&amp;pages=695-706&amp;pmid=10204198&amp;doi=10.1002/(sici)1097-0258(19990330)18:6&lt;695::aid-sim60&gt;3.0.co;2-o&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="j_jtim-2025-0032_ref_026">
<span class="label">26.</span><cite>Lv M, Shen M, Mo X. Development of allogeneic hematopoietic stem cell transplantation in 2022: Regenerating “Groot” to heal the world. Innovation (Camb) 2023;4:100373. doi: 10.1016/j.xinn.2023.100373.</cite> [<a href="https://doi.org/10.1016/j.xinn.2023.100373" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9923186/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36794169/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Innovation%20(Camb)&amp;title=Development%20of%20allogeneic%20hematopoietic%20stem%20cell%20transplantation%20in%202022:%20Regenerating%20%E2%80%9CGroot%E2%80%9D%20to%20heal%20the%20world&amp;author=M%20Lv&amp;author=M%20Shen&amp;author=X%20Mo&amp;volume=4&amp;publication_year=2023&amp;pages=100373&amp;pmid=36794169&amp;doi=10.1016/j.xinn.2023.100373&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="j_jtim-2025-0032_ref_027">
<span class="label">27.</span><cite>Buccisano F, Maurillo L, Piciocchi A, Del Principe MI, Picardi A, Cerretti R. Pre-transplant persistence of minimal residual disease does not contraindicate allogeneic stem cell transplantation for adult patients with acute myeloid leukemia. Bone Marrow Transplant. 2017;52:473. doi: 10.1038/bmt.2016.308. et al. -</cite> [<a href="https://doi.org/10.1038/bmt.2016.308" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27941782/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Bone%20Marrow%20Transplant&amp;title=Pre-transplant%20persistence%20of%20minimal%20residual%20disease%20does%20not%20contraindicate%20allogeneic%20stem%20cell%20transplantation%20for%20adult%20patients%20with%20acute%20myeloid%20leukemia&amp;author=F%20Buccisano&amp;author=L%20Maurillo&amp;author=A%20Piciocchi&amp;author=Principe%20MI%20Del&amp;author=A%20Picardi&amp;volume=52&amp;publication_year=2017&amp;pages=473-475&amp;pmid=27941782&amp;doi=10.1038/bmt.2016.308&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="j_jtim-2025-0032_ref_028">
<span class="label">28.</span><cite>Chang YJ, Wang Y, Liu YR, Xu LP, Zhang XH, Chen H. Haploidentical allograft is superior to matched sibling donor allograft in eradicating pre-transplantation minimal residual disease of AML patients as determined by multiparameter flow cytometry: a retrospective and prospective analysis. J Hematol Oncol. 2017;10:134. doi: 10.1186/s13045-017-0502-3. et al.</cite> [<a href="https://doi.org/10.1186/s13045-017-0502-3" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5496245/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28676064/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Hematol%20Oncol&amp;title=Haploidentical%20allograft%20is%20superior%20to%20matched%20sibling%20donor%20allograft%20in%20eradicating%20pre-transplantation%20minimal%20residual%20disease%20of%20AML%20patients%20as%20determined%20by%20multiparameter%20flow%20cytometry:%20a%20retrospective%20and%20prospective%20analysis&amp;author=YJ%20Chang&amp;author=Y%20Wang&amp;author=YR%20Liu&amp;author=LP%20Xu&amp;author=XH%20Zhang&amp;volume=10&amp;publication_year=2017&amp;pages=134&amp;pmid=28676064&amp;doi=10.1186/s13045-017-0502-3&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="j_jtim-2025-0032_ref_029">
<span class="label">29.</span><cite>Chang YJ, Pei XY, Huang XJ. Haematopoietic stem-cell transplantation in China in the era of targeted therapies: current advances, challenges, and future directions. Lancet Haematol. 2022;9:e919. doi: 10.1016/S2352-3026(22)00293-9. -</cite> [<a href="https://doi.org/10.1016/S2352-3026(22)00293-9" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36455607/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Lancet%20Haematol&amp;title=Haematopoietic%20stem-cell%20transplantation%20in%20China%20in%20the%20era%20of%20targeted%20therapies:%20current%20advances,%20challenges,%20and%20future%20directions&amp;author=YJ%20Chang&amp;author=XY%20Pei&amp;author=XJ%20Huang&amp;volume=9&amp;publication_year=2022&amp;pages=e919-e929&amp;pmid=36455607&amp;doi=10.1016/S2352-3026(22)00293-9&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="j_jtim-2025-0032_ref_030">
<span class="label">30.</span><cite>Cai Z, Fan S, Sun X, Mo X, Yang G. Novel microfluidic device for measurable residual disease detection in acute leukemia. Innovation (Camb) 2023;4:100408. doi: 10.1016/j.xinn.2023.100408.</cite> [<a href="https://doi.org/10.1016/j.xinn.2023.100408" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10060743/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37008987/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Innovation%20(Camb)&amp;title=Novel%20microfluidic%20device%20for%20measurable%20residual%20disease%20detection%20in%20acute%20leukemia&amp;author=Z%20Cai&amp;author=S%20Fan&amp;author=X%20Sun&amp;author=X%20Mo&amp;author=G%20Yang&amp;volume=4&amp;publication_year=2023&amp;pages=100408&amp;pmid=37008987&amp;doi=10.1016/j.xinn.2023.100408&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="j_jtim-2025-0032_ref_031">
<span class="label">31.</span><cite>Kayser S, Hills RK, Luskin MR, Brunner AM, Terré C, Westermann J. Allogeneic hematopoietic cell transplantation improves outcome of adults with t(6;9) acute myeloid leukemia: results from an international collaborative study. Haematologica. 2020;105:161. doi: 10.3324/haematol.2018.208678. et al. -</cite> [<a href="https://doi.org/10.3324/haematol.2018.208678" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6939530/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31004014/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Haematologica&amp;title=Allogeneic%20hematopoietic%20cell%20transplantation%20improves%20outcome%20of%20adults%20with%20t(6;9)%20acute%20myeloid%20leukemia:%20results%20from%20an%20international%20collaborative%20study&amp;author=S%20Kayser&amp;author=RK%20Hills&amp;author=MR%20Luskin&amp;author=AM%20Brunner&amp;author=C%20Terr%C3%A9&amp;volume=105&amp;publication_year=2020&amp;pages=161-169&amp;pmid=31004014&amp;doi=10.3324/haematol.2018.208678&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="j_jtim-2025-0032_ref_032">
<span class="label">32.</span><cite>Wang Y, Liu QF, Xu LP, Liu KY, Zhang XH, Ma X. Haploidentical vs identical-sibling transplant for AML in remission: a multicenter, prospective study. Blood. 2015;125:3956. doi: 10.1182/blood-2015-02-627786. et al. -</cite> [<a href="https://doi.org/10.1182/blood-2015-02-627786" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25940714/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Blood&amp;title=Haploidentical%20vs%20identical-sibling%20transplant%20for%20AML%20in%20remission:%20a%20multicenter,%20prospective%20study&amp;author=Y%20Wang&amp;author=QF%20Liu&amp;author=LP%20Xu&amp;author=KY%20Liu&amp;author=XH%20Zhang&amp;volume=125&amp;publication_year=2015&amp;pages=3956-3962&amp;pmid=25940714&amp;doi=10.1182/blood-2015-02-627786&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="j_jtim-2025-0032_ref_033">
<span class="label">33.</span><cite>Huang T, Xu L, Zhang X, Chang Y, Mo X, Sun Y. Haploidentical haematopoietic stem cell transplantation for TP53-mutated acute myeloid leukaemia. Br J Haematol. 2023;200:494. doi: 10.1111/bjh.18538. et al. -</cite> [<a href="https://doi.org/10.1111/bjh.18538" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36345800/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Br%20J%20Haematol&amp;title=Haploidentical%20haematopoietic%20stem%20cell%20transplantation%20for%20TP53-mutated%20acute%20myeloid%20leukaemia&amp;author=T%20Huang&amp;author=L%20Xu&amp;author=X%20Zhang&amp;author=Y%20Chang&amp;author=X%20Mo&amp;volume=200&amp;publication_year=2023&amp;pages=494-505&amp;pmid=36345800&amp;doi=10.1111/bjh.18538&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="j_jtim-2025-0032_ref_034">
<span class="label">34.</span><cite>Wang Y, Liu DH, Xu LP, Liu KY, Chen H. Superior graft-versus-leukemia effect associated with transplantation of haploidentical compared with HLA-identical sibling donor grafts for high-risk acute leukemia: an historic comparison. Biol Blood Marrow Transplant. 2011;17:821. doi: 10.1016/j.bbmt.2010.08.023. et al. -</cite> [<a href="https://doi.org/10.1016/j.bbmt.2010.08.023" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20831895/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Biol%20Blood%20Marrow%20Transplant&amp;title=Superior%20graft-versus-leukemia%20effect%20associated%20with%20transplantation%20of%20haploidentical%20compared%20with%20HLA-identical%20sibling%20donor%20grafts%20for%20high-risk%20acute%20leukemia:%20an%20historic%20comparison&amp;author=Y%20Wang&amp;author=DH%20Liu&amp;author=LP%20Xu&amp;author=KY%20Liu&amp;author=H%20Chen&amp;volume=17&amp;publication_year=2011&amp;pages=821-830&amp;pmid=20831895&amp;doi=10.1016/j.bbmt.2010.08.023&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="j_jtim-2025-0032_ref_035">
<span class="label">35.</span><cite>Cho BS, Min GJ, Park S, Park SS, Shin SH, Yahng SA. Haploidentical vs matched unrelated donor transplantation for acute myeloid leukemia in remission: A prospective comparative study. Am J Hematol. 2021;96:98. doi: 10.1002/ajh.25993. et al. -</cite> [<a href="https://doi.org/10.1002/ajh.25993" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32905642/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Am%20J%20Hematol&amp;title=Haploidentical%20vs%20matched%20unrelated%20donor%20transplantation%20for%20acute%20myeloid%20leukemia%20in%20remission:%20A%20prospective%20comparative%20study&amp;author=BS%20Cho&amp;author=GJ%20Min&amp;author=S%20Park&amp;author=SS%20Park&amp;author=SH%20Shin&amp;volume=96&amp;publication_year=2021&amp;pages=98-109&amp;pmid=32905642&amp;doi=10.1002/ajh.25993&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="j_jtim-2025-0032_ref_036">
<span class="label">36.</span><cite>Oyarzo MP, Lin P, Glassman A, Bueso-Ramos CE, Luthra R, Medeiros LJ. Acute myeloid leukemia with t(6;9)(p23;q34) is associated with dysplasia and a high frequency of flt3 gene mutations. Am J Clin Pathol. 2004;122:348. doi: 10.1309/5DGB-59KQ-A527-PD47. -</cite> [<a href="https://doi.org/10.1309/5DGB-59KQ-A527-PD47" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/15362364/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Am%20J%20Clin%20Pathol&amp;title=Acute%20myeloid%20leukemia%20with%20t(6;9)(p23;q34)%20is%20associated%20with%20dysplasia%20and%20a%20high%20frequency%20of%20flt3%20gene%20mutations&amp;author=MP%20Oyarzo&amp;author=P%20Lin&amp;author=A%20Glassman&amp;author=CE%20Bueso-Ramos&amp;author=R%20Luthra&amp;volume=122&amp;publication_year=2004&amp;pages=348-358&amp;pmid=15362364&amp;doi=10.1309/5DGB-59KQ-A527-PD47&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="j_jtim-2025-0032_ref_037">
<span class="label">37.</span><cite>Stahl M, Tallman MS. Outcomes of allogeneic stem cell transplantation for patients with t(6:9) AML- A strong case for allogeneic stem cell transplantation in first complete remission. Br J Haematol. 2020;189:806. doi: 10.1111/bjh.16478. -</cite> [<a href="https://doi.org/10.1111/bjh.16478" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31999852/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Br%20J%20Haematol&amp;title=Outcomes%20of%20allogeneic%20stem%20cell%20transplantation%20for%20patients%20with%20t(6:9)%20AML-%20A%20strong%20case%20for%20allogeneic%20stem%20cell%20transplantation%20in%20first%20complete%20remission&amp;author=M%20Stahl&amp;author=MS%20Tallman&amp;volume=189&amp;publication_year=2020&amp;pages=806-808&amp;pmid=31999852&amp;doi=10.1111/bjh.16478&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="j_jtim-2025-0032_ref_038">
<span class="label">38.</span><cite>Mendes A, Fahrenkrog B. NUP214 in Leukemia: It’s More than Transport. Cells. 2019;8:76. doi: 10.3390/cells8010076.</cite> [<a href="https://doi.org/10.3390/cells8010076" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6356203/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30669574/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cells&amp;title=NUP214%20in%20Leukemia:%20It%E2%80%99s%20More%20than%20Transport&amp;author=A%20Mendes&amp;author=B%20Fahrenkrog&amp;volume=8&amp;publication_year=2019&amp;pages=76&amp;pmid=30669574&amp;doi=10.3390/cells8010076&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="j_jtim-2025-0032_ref_039">
<span class="label">39.</span><cite>Takeda A, Yaseen NR. Nucleoporins and nucleocytoplasmic transport in hematologic malignancies. Semin Cancer Biol. 2014;27:3. doi: 10.1016/j.semcancer.2014.02.009. -</cite> [<a href="https://doi.org/10.1016/j.semcancer.2014.02.009" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24657637/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Semin%20Cancer%20Biol&amp;title=Nucleoporins%20and%20nucleocytoplasmic%20transport%20in%20hematologic%20malignancies&amp;author=A%20Takeda&amp;author=NR%20Yaseen&amp;volume=27&amp;publication_year=2014&amp;pages=3-10&amp;pmid=24657637&amp;doi=10.1016/j.semcancer.2014.02.009&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="j_jtim-2025-0032_ref_040">
<span class="label">40.</span><cite>Xuan L, Wang Y, Huang F, Fan Z, Xu Y, Sun J. Sorafenib maintenance in patients with FLT3-ITD acute myeloid leukaemia undergoing allogeneic haematopoietic stem-cell transplantation: an open-label, multicentre, randomised phase 3 trial. Lancet Oncol. 2020;21:1201. doi: 10.1016/S1470-2045(20)30455-1. et al. -</cite> [<a href="https://doi.org/10.1016/S1470-2045(20)30455-1" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32791048/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Lancet%20Oncol&amp;title=Sorafenib%20maintenance%20in%20patients%20with%20FLT3-ITD%20acute%20myeloid%20leukaemia%20undergoing%20allogeneic%20haematopoietic%20stem-cell%20transplantation:%20an%20open-label,%20multicentre,%20randomised%20phase%203%20trial&amp;author=L%20Xuan&amp;author=Y%20Wang&amp;author=F%20Huang&amp;author=Z%20Fan&amp;author=Y%20Xu&amp;volume=21&amp;publication_year=2020&amp;pages=1201-1212&amp;pmid=32791048&amp;doi=10.1016/S1470-2045(20)30455-1&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="j_jtim-2025-0032_ref_041">
<span class="label">41.</span><cite>Xuan L, Wang Y, Yang K, Shao R, Huang F, Fan Z. Sorafenib maintenance after allogeneic haemopoietic stem-cell transplantation in patients with FLT3-ITD acute myeloid leukaemia: long-term follow-up of an open-label, multicentre, randomised, phase 3 trial. Lancet Haematol. 2023;10:e600. doi: 10.1016/S2352-3026(23)00117-5. et al. -</cite> [<a href="https://doi.org/10.1016/S2352-3026(23)00117-5" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37414062/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Lancet%20Haematol&amp;title=Sorafenib%20maintenance%20after%20allogeneic%20haemopoietic%20stem-cell%20transplantation%20in%20patients%20with%20FLT3-ITD%20acute%20myeloid%20leukaemia:%20long-term%20follow-up%20of%20an%20open-label,%20multicentre,%20randomised,%20phase%203%20trial&amp;author=L%20Xuan&amp;author=Y%20Wang&amp;author=K%20Yang&amp;author=R%20Shao&amp;author=F%20Huang&amp;volume=10&amp;publication_year=2023&amp;pages=e600-e611&amp;pmid=37414062&amp;doi=10.1016/S2352-3026(23)00117-5&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="j_jtim-2025-0032_ref_042">
<span class="label">42.</span><cite>Levis MJ. BMT CTN. 1506/MORPHO trial which evaluated maintenance gilteritinib after allogeneic stem cell transplant in patients with FLT3-ITD–positive acute myeloid leukemia. <a href="https://www.targetedonc.com/view/key-data-from-the-bmt-ctn-1506-morpho-trialof-gilteritinib-in-flt3-itdaml" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://www.targetedonc.com/view/key-data-from-the-bmt-ctn-1506-morpho-trialof-gilteritinib-in-flt3-itdaml</a> <a href="https://www.targetedonc.com/view/key-data-from-the-bmt-ctn-1506-morpho-trialof-gilteritinib-in-flt3-itdaml" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://www.targetedonc.com/view/key-data-from-the-bmt-ctn-1506-morpho-trialof-gilteritinib-in-flt3-itdaml</a> Available from.</cite>
</li>
</ul></section></section></section><footer class="p courtesy-note font-secondary font-sm text-center"><hr class="headless">
<p>Articles from Journal of Translational Internal Medicine are provided here courtesy of <strong>De Gruyter</strong></p></footer></section></article>

                      

                    </main>
                </div>
            </div>
        </div>

        



<!-- Secondary navigation placeholder -->
<div class="pmc-sidenav desktop:grid-col-4 display-flex">
    <section class="pmc-sidenav__container" aria-label="Article resources and navigation">
        <button type="button" class="usa-button pmc-sidenav__container__close usa-button--unstyled">
            <img src="/static/img/usa-icons/close.svg" role="img" alt="Close" />
        </button>
    <div class="display-none desktop:display-block">
       <section class="margin-top-4 desktop:margin-top-0">
              <h2 class="margin-top-0">ACTIONS</h2>
           <ul class="usa-list usa-list--unstyled usa-list--actions">
               
               <li>
                     <a
                             href="https://doi.org/10.1515/jtim-2025-0032"
                             class="usa-button usa-button--outline width-24 font-xs display-inline-flex flex-align-center flex-justify-start padding-left-1"
                             target="_blank"
                             rel="noreferrer noopener"
                             data-ga-category="actions"
                             data-ga-action="click"
                             data-ga-label="publisher_link_desktop"
                     >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#launch"></use>
                         </svg>
                         <span class="display-inline-flex flex-justify-center flex-1 padding-right-2">View on publisher site</span>
                     </a>
               </li>
               
               
               <li>
                    <a
                            href="pdf/jtim-13-4-jtim-2025-0032.pdf"
                            class="usa-button usa-button--outline width-24 display-inline-flex flex-align-center flex-justify-start padding-left-1"
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="pdf_download_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#file_download"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1">PDF (1.7 MB)</span>
                    </a>
               </li>
               
                
               <li>
                   <button role="button" class="usa-button width-24 citation-dialog-trigger display-inline-flex flex-align-center flex-justify-start padding-left-1"
                        aria-label="Open dialog with citation text in different styles"
                        data-ga-category="actions"
                        data-ga-action="open"
                        data-ga-label="cite_desktop"
                        data-all-citations-url="/resources/citations/12371398/"
                        data-citation-style="nlm"
                        data-download-format-link="/resources/citations/12371398/export/"
                    >
                        <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                        </svg>
                       <span class="display-inline-flex flex-justify-center flex-1 button-label">Cite</span>
                    </button>
               </li>
                
               <li>

                        <button class="usa-button width-24 collections-dialog-trigger collections-button display-inline-flex flex-align-center flex-justify-start padding-left-1 collections-button-empty"
                              aria-label="Save article in MyNCBI collections."
                              data-ga-category="actions"
                              data-ga-action="click"
                              data-ga-label="collections_button_desktop"
                              data-collections-open-dialog-enabled="false"
                              data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12371398%2F%3Freport%3Dclassic%23open-collections-dialog"
                              data-in-collections="false">
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                            <span class="display-inline-flex flex-justify-center flex-1">Collections</span>
                       </button>
               </li>
               <li class="pmc-permalink">
                    <button
                            type="button"
                            class="usa-button width-24 display-inline-flex flex-align-center flex-justify padding-left-1 shadow-none"
                            aria-label="Show article permalink"
                            aria-expanded="false"
                            aria-haspopup="true"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="permalink_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#share"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1 button-label">Permalink</span>
                    </button>
                   

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12371398/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
               </li>
           </ul>
       </section>
     </div>

        <section class="pmc-resources margin-top-6 desktop:margin-top-4" data-page-path="/articles/PMC12371398/">
            <h2 class="margin-top-0">RESOURCES</h2>
            
                <div class="usa-accordion usa-accordion--multiselectable" data-allow-multiple>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-similar-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_similar_articles"
                        data-ga-label="/articles/PMC12371398/"
                        data-action-open="open_similar_articles"
                        data-action-close="close_similar_articles"
                        >
                            Similar articles
                        </button>
                    </h3>
                    <div
                            id="resources-similar-articles"
                            class="usa-accordion__content usa-prose"
                            
                    >
                        
                    </div>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-cited-by-other-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_cited_by"
                        data-ga-label="/articles/PMC12371398/"
                        data-action-open="open_cited_by"
                        data-action-close="close_cited_by"
                        >
                             Cited by other articles
                        </button>
                    </h3>
                    <div
                            id="resources-cited-by-other-articles"
                            class="usa-accordion__content usa-prose"
                            
                    >
                          
                    </div>
                    
                        <h3 class="usa-accordion__heading">
                            <button
                            type="button"
                            class="usa-accordion__button"
                            aria-expanded="false"
                            aria-controls="resources-links-to-ncbi-databases"
                            data-ga-category="resources_accordion"
                            data-ga-action="open_NCBI_links"
                            data-ga-label="/articles/PMC12371398/"
                            data-action-open="open_NCBI_links"
                            data-action-close="close_NCBI_link"
                            >
                                 Links to NCBI Databases
                            </button>
                        </h3>
                        <div
                                id="resources-links-to-ncbi-databases"
                                class="usa-accordion__content usa-prose"
                                data-source-url="/resources/db-links/12371398/"
                        >
                        </div>
                    
                    
                </div>
            
        </section>


        <section
        class="usa-in-page-nav usa-in-page-nav--wide margin-top-6 desktop:margin-top-4"
        data-title-text="On this page"
        data-title-heading-level="h2"
        data-scroll-offset="0"
        data-root-margin="-10% 0px -80% 0px"
        data-main-content-selector="main"
        data-threshold="1"
        hidden
        ></section>
    </section>
</div>


        

<div class="overlay" role="dialog" aria-label="Citation Dialog" hidden>
    <div class="dialog citation-dialog" aria-hidden="true">
        <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
            <h2 class="usa-modal__heading margin-0">Cite</h2>
             <button type="button" class="usa-button usa-button--unstyled close-overlay text-black width-auto"  tabindex="1">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
             </button>
        </div>

        

<div class="citation-text-block">
  <div class="citation-text margin-bottom-2"></div>
  <ul class="usa-list usa-list--unstyled display-inline-flex flex-justify width-full flex-align-center">
      <li>
        <button
          class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center copy-button dialog-focus"
          data-ga-category="save_share"
          data-ga-action="cite"
          data-ga-label="copy"
          tabindex="2">
            <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                <use xlink:href="/static/img/sprite.svg#content_copy"></use>
            </svg>
            <span>Copy</span>
        </button>
      </li>
      <li>
          <a
              href="#"
              role="button"
              class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center export-button"
              data-ga-category="save_share"
              data-ga-action="cite"
              data-ga-label="download"
              title="Download a file for external citation management software"
              tabindex="3">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                </svg>
                <span class="display-none mobile-lg:display-inline">Download .nbib</span>
                <span class="display-inline mobile-lg:display-none">.nbib</span>
            </a>
      </li>
      <li>
          

<div class="display-inline-flex flex-align-center">
  <label class="usa-label margin-top-0">Format:</label>
  <select aria-label="Format" class="usa-select citation-style-selector padding-1 margin-top-0 border-0 padding-right-4" tabindex="4" >
    
      <option data-style-url-name="ama"
              value="AMA"
              >
        AMA
      </option>
    
      <option data-style-url-name="apa"
              value="APA"
              >
        APA
      </option>
    
      <option data-style-url-name="mla"
              value="MLA"
              >
        MLA
      </option>
    
      <option data-style-url-name="nlm"
              value="NLM"
              selected="selected">
        NLM
      </option>
    
  </select>
</div>
      </li>
  </ul>
</div>
    </div>
</div>

        <div class="overlay" role="dialog" hidden>
  <div id="collections-action-dialog" class="dialog collections-dialog" aria-hidden="true">
   <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
        <h2 class="usa-modal__heading margin-0">Add to Collections</h2>
    </div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form"
      class="usa-form maxw-full collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors"
      data-existing-collections-url="/list-existing-collections/"
      data-add-to-existing-collection-url="/add-to-existing-collection/"
      data-create-and-add-to-new-collection-url="/create-and-add-to-new-collection/"
      data-myncbi-max-collection-name-length="100"
      data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

    <input type="hidden" name="csrfmiddlewaretoken" value="rknSWq1PyiiB3YEOe6laOevYYSQ9KiKccYZkGmKxu3mxK3YiD8SW5Wj95EaMTsNm">

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-new"
            class="usa-radio__input usa-radio__input--tile collections-new  margin-top-0"
            name="collections"
            value="new"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_new" />
            <label class="usa-radio__label" for="collections-action-dialog-new">Create a new collection</label>
        </div>
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-existing"
            class="usa-radio__input usa-radio__input--tile collections-existing"
            name="collections"
            value="existing"
            checked="true"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_existing" />
            <label class="usa-radio__label" for="collections-action-dialog-existing">Add to an existing collection</label>
        </div>
    </fieldset>

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="action-panel-control-wrap new-collections-controls">
           <label for="collections-action-dialog-add-to-new" class="usa-label margin-top-0">
                Name your collection
               <abbr title="required" class="usa-hint usa-hint--required text-no-underline">*</abbr>
          </label>
          <input
            type="text"
            name="add-to-new-collection"
            id="collections-action-dialog-add-to-new"
            class="usa-input collections-action-add-to-new"
            pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/"
            maxlength=""
            data-ga-category="collections_button"
            data-ga-action="create_collection"
            data-ga-label="non_favorties_collection"
            required
          />
        </div>
        <div class="action-panel-control-wrap existing-collections-controls">
             <label for="collections-action-dialog-add-to-existing" class="usa-label margin-top-0">
                Choose a collection
              </label>
              <select id="collections-action-dialog-add-to-existing"
                      class="usa-select collections-action-add-to-existing"
                      data-ga-category="collections_button"
                      data-ga-action="select_collection"
                      data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
              </select>
              <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
                Unable to load your collection due to an error<br>
                <a href="#">Please try again</a>
              </div>
        </div>
    </fieldset>

    <div class="display-inline-flex">
        <button class="usa-button margin-top-0 action-panel-submit"
            type="submit"
            data-loading-label="Adding..."
            data-pinger-ignore
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="add">
          Add
        </button>
        <button class="usa-button usa-button--outline margin-top-0 action-panel-cancel"
                aria-label="Close 'Add to Collections' panel"
                ref="linksrc=close_collections_panel"
                data-ga-category="collections_button"
                data-ga-action="click"
                data-ga-label="cancel">
          Cancel
        </button>
    </div>
</form>
    </div>
  </div>
</div>

        

      </div>
    </div>
  </div>



        
    
    

<footer class="ncbi-footer ncbi-dark-background " >
    
        <div class="ncbi-footer__icon-section">
            <div class="ncbi-footer__social-header">
                Follow NCBI
            </div>

            <div class="grid-container ncbi-footer__ncbi-social-icons-container">
                
                    <a href="https://twitter.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="40"
                             height="40"
                             viewBox="0 0 40 40"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on X (formerly known as Twitter)</span>
                    </a>
                

                
                    <a href="https://www.facebook.com/ncbi.nlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="16"
                             height="29"
                             focusable="false"
                             aria-hidden="true"
                             viewBox="0 0 16 29"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg">
                            <path d="M3.8809 21.4002C3.8809 19.0932 3.8809 16.7876 3.8809 14.478C3.8809 14.2117 3.80103 14.1452 3.54278 14.1492C2.53372 14.1638 1.52334 14.1492 0.514288 14.1598C0.302626 14.1598 0.248047 14.0972 0.248047 13.8936C0.256034 12.4585 0.256034 11.0239 0.248047 9.58978C0.248047 9.37013 0.302626 9.30224 0.528931 9.3049C1.53798 9.31688 2.54837 9.3049 3.55742 9.31555C3.80103 9.31555 3.8809 9.26097 3.87957 9.00272C3.87158 8.00565 3.85428 7.00592 3.90753 6.00884C3.97142 4.83339 4.31487 3.73115 5.04437 2.78467C5.93095 1.63318 7.15699 1.09005 8.56141 0.967577C10.5582 0.79319 12.555 0.982221 14.5518 0.927641C14.7102 0.927641 14.7462 0.99287 14.7449 1.13664C14.7449 2.581 14.7449 4.02668 14.7449 5.47104C14.7449 5.67604 14.6517 5.68669 14.4946 5.68669C13.4523 5.68669 12.4113 5.68669 11.3703 5.68669C10.3506 5.68669 9.92057 6.10868 9.90593 7.13904C9.89661 7.7647 9.91525 8.39303 9.89794 9.01869C9.88995 9.26364 9.96583 9.31822 10.2015 9.31688C11.7204 9.30623 13.2393 9.31688 14.7595 9.3049C15.0257 9.3049 15.0723 9.3728 15.0444 9.62439C14.89 10.9849 14.7515 12.3467 14.6144 13.7085C14.5691 14.1571 14.5785 14.1585 14.1458 14.1585C12.8386 14.1585 11.5313 14.1665 10.2254 14.1518C9.95119 14.1518 9.89794 14.2317 9.89794 14.4899C9.90593 19.0799 9.89794 23.6752 9.91125 28.2612C9.91125 28.5674 9.8407 28.646 9.53186 28.6433C7.77866 28.6273 6.02414 28.6366 4.27094 28.634C3.82499 28.634 3.87158 28.6992 3.87158 28.22C3.87602 25.9472 3.87913 23.6739 3.8809 21.4002Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on Facebook</span>
                    </a>
                

                
                    <a href="https://www.linkedin.com/company/ncbinlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="25"
                             height="23"
                             viewBox="0 0 26 24"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M14.6983 9.98423C15.6302 9.24808 16.5926 8.74754 17.6762 8.51991C19.673 8.09126 21.554 8.30824 23.1262 9.7526C24.2351 10.7723 24.7529 12.1115 25.0165 13.5612C25.1486 14.3363 25.2105 15.1218 25.2015 15.9081C25.2015 18.3043 25.2015 20.6898 25.2082 23.0806C25.2082 23.3468 25.1549 23.444 24.8621 23.4414C23.1297 23.4272 21.3992 23.4272 19.6704 23.4414C19.4041 23.4414 19.3429 23.3588 19.3442 23.1019C19.3535 20.5194 19.3442 17.9368 19.3442 15.3543C19.3442 14.0005 18.3258 12.9448 17.0266 12.9488C15.7273 12.9528 14.6983 14.0071 14.6983 15.361C14.6983 17.9328 14.6917 20.5047 14.6983 23.0753C14.6983 23.3708 14.6198 23.444 14.3296 23.4427C12.6185 23.4294 10.9079 23.4294 9.19779 23.4427C8.93155 23.4427 8.86099 23.3735 8.86232 23.1086C8.8783 19.7619 8.88628 16.4144 8.88628 13.066C8.88628 11.5688 8.87874 10.0708 8.86365 8.57182C8.86365 8.3575 8.90758 8.27896 9.14054 8.28029C10.9048 8.29094 12.6687 8.29094 14.4321 8.28029C14.6464 8.28029 14.6983 8.34818 14.6983 8.54653C14.6903 9.00047 14.6983 9.45441 14.6983 9.98423Z">
                            </path>
                            <path d="M6.55316 15.8443C6.55316 18.2564 6.55316 20.6699 6.55316 23.082C6.55316 23.3629 6.48127 23.4388 6.19906 23.4374C4.47737 23.4241 2.75568 23.4241 1.03399 23.4374C0.767751 23.4374 0.69986 23.3629 0.701191 23.1006C0.709178 18.2648 0.709178 13.4281 0.701191 8.59053C0.701191 8.34026 0.765089 8.27237 1.01669 8.2737C2.74991 8.28435 4.48048 8.28435 6.20838 8.2737C6.47462 8.2737 6.5465 8.33627 6.54517 8.6065C6.54783 11.0186 6.55316 13.4308 6.55316 15.8443Z">
                            </path>
                            <path d="M3.65878 0.243898C5.36804 0.243898 6.58743 1.45529 6.58743 3.1406C6.58743 4.75801 5.32145 5.95742 3.60819 5.96807C3.22177 5.97614 2.83768 5.90639 2.47877 5.76299C2.11985 5.61959 1.79344 5.40546 1.51897 5.13334C1.24449 4.86123 1.02755 4.53668 0.881058 4.17902C0.734563 3.82136 0.661505 3.43788 0.666231 3.05141C0.67555 1.42601 1.9362 0.242566 3.65878 0.243898Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on LinkedIn</span>
                    </a>
                

                
                    <a href="https://github.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="28"
                             height="27"
                             viewBox="0 0 28 28"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M16.7228 20.6334C17.5057 20.5527 18.2786 20.3944 19.0301 20.1608C21.3108 19.4193 22.5822 17.8259 22.963 15.4909C23.1228 14.5112 23.1814 13.5287 22.9883 12.5437C22.8106 11.6423 22.4013 10.8028 21.8007 10.1076C21.7526 10.0605 21.7197 10 21.7064 9.934C21.6931 9.86799 21.7 9.79952 21.7262 9.73748C22.0856 8.6206 21.9711 7.51969 21.601 6.42677C21.582 6.3497 21.5345 6.2827 21.468 6.23923C21.4016 6.19577 21.3211 6.17906 21.2429 6.19248C20.7329 6.21649 20.2313 6.33051 19.7611 6.52928C19.1103 6.7908 18.4899 7.12198 17.9104 7.51703C17.84 7.56996 17.7581 7.60551 17.6713 7.62078C17.5846 7.63605 17.4954 7.6306 17.4112 7.60489C15.2596 7.05882 13.0054 7.06203 10.8554 7.61421C10.7806 7.63586 10.7018 7.63967 10.6253 7.62534C10.5487 7.611 10.4766 7.57892 10.4148 7.53167C9.64788 7.03247 8.85171 6.58918 7.96368 6.33359C7.65781 6.24338 7.34123 6.19458 7.02239 6.18849C6.94879 6.17986 6.87462 6.19893 6.81432 6.242C6.75402 6.28507 6.71191 6.34904 6.69621 6.42145C6.32342 7.51437 6.2209 8.61527 6.56307 9.73348C6.59635 9.84264 6.64694 9.93316 6.54177 10.0516C5.47666 11.2604 5.09988 12.6834 5.19574 14.2676C5.2663 15.4244 5.46201 16.5466 6.01454 17.5769C6.84399 19.1171 8.21664 19.9119 9.85158 20.3352C10.3938 20.4706 10.9444 20.5698 11.4998 20.632C11.5384 20.7492 11.4506 20.7798 11.408 20.8291C11.1734 21.1179 10.9894 21.4441 10.8634 21.7942C10.7622 22.0458 10.8315 22.4039 10.6065 22.5516C10.263 22.7766 9.83827 22.8485 9.42421 22.8871C8.17936 23.0056 7.26471 22.4877 6.6283 21.4348C6.25552 20.8184 5.76956 20.3325 5.08523 20.0663C4.76981 19.9325 4.42139 19.8967 4.08537 19.9638C3.7898 20.029 3.73788 20.1901 3.93891 20.4111C4.03639 20.5234 4.14989 20.6207 4.27575 20.6999C4.9796 21.1318 5.51717 21.7884 5.80152 22.5636C6.37002 23.9973 7.48039 24.5697 8.93825 24.6323C9.43741 24.6575 9.93768 24.615 10.4254 24.5058C10.5892 24.4672 10.6531 24.4872 10.6517 24.6762C10.6451 25.4936 10.6637 26.3123 10.6517 27.131C10.6517 27.6635 10.1684 27.9297 9.58663 27.7393C8.17396 27.2671 6.84977 26.5631 5.66838 25.656C2.59555 23.2891 0.720966 20.1861 0.217704 16.3376C-0.357453 11.9127 0.911353 8.00824 3.98551 4.73881C6.11909 2.42656 8.99932 0.939975 12.1203 0.540191C16.5351 -0.0601815 20.4347 1.14323 23.7232 4.16373C26.2449 6.47869 27.724 9.37672 28.1048 12.7726C28.5828 17.0325 27.3686 20.7945 24.4768 23.9827C22.9762 25.6323 21.0956 26.8908 18.9982 27.6488C18.8783 27.6927 18.7585 27.738 18.636 27.7726C18.0356 27.9404 17.6189 27.6395 17.6189 27.0098C17.6189 25.7452 17.6308 24.4806 17.6295 23.2159C17.6329 22.9506 17.6128 22.6856 17.5696 22.4238C17.4325 21.6664 17.3419 21.484 16.7228 20.6334Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on GitHub</span>
                    </a>
                

                
                    <a href="https://ncbiinsights.ncbi.nlm.nih.gov/"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="26"
                             height="26"
                             viewBox="0 0 27 27"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M23.7778 26.4574C23.1354 26.3913 22.0856 26.8024 21.636 26.3087C21.212 25.8444 21.4359 24.8111 21.324 24.0347C19.9933 14.8323 14.8727 8.80132 6.09057 5.85008C4.37689 5.28406 2.58381 4.99533 0.779072 4.99481C0.202773 4.99481 -0.0229751 4.83146 0.00455514 4.21479C0.0660406 3.08627 0.0660406 1.95525 0.00455514 0.826734C-0.0413285 0.0815827 0.259669 -0.0193618 0.896534 0.00266238C6.96236 0.222904 12.3693 2.24179 16.9889 6.16209C22.9794 11.2478 26.1271 17.7688 26.4372 25.648C26.4629 26.294 26.3179 26.5271 25.6609 26.4684C25.0827 26.417 24.4991 26.4574 23.7778 26.4574Z">
                            </path>
                            <path d="M14.8265 26.441C14.0924 26.441 13.2371 26.6795 12.6626 26.3786C12.0092 26.0372 12.3781 25.0644 12.246 24.378C11.1154 18.5324 6.6849 14.5497 0.74755 14.1001C0.217135 14.0615 -0.0104482 13.9422 0.0134113 13.3659C0.0519536 12.1454 0.0482829 10.9213 0.0134113 9.69524C-0.00127145 9.14464 0.196946 9.03268 0.703502 9.04736C9.21217 9.27128 16.5994 16.2511 17.2804 24.7231C17.418 26.4446 17.418 26.4446 15.6579 26.4446H14.832L14.8265 26.441Z">
                            </path>
                            <path d="M3.58928 26.4555C2.64447 26.4618 1.73584 26.0925 1.06329 25.4289C0.39073 24.7653 0.00933763 23.8617 0.0030097 22.9169C-0.00331824 21.9721 0.365937 21.0635 1.02954 20.3909C1.69315 19.7184 2.59675 19.337 3.54156 19.3306C4.48637 19.3243 5.39499 19.6936 6.06755 20.3572C6.7401 21.0208 7.1215 21.9244 7.12782 22.8692C7.13415 23.814 6.7649 24.7226 6.10129 25.3952C5.43768 26.0677 4.53409 26.4491 3.58928 26.4555Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI RSS feed</span>
                    </a>
                
            </div>
        </div>
    

    <div data-testid="gridContainer"
         class="grid-container ncbi-footer__container">
        <div class="grid-row ncbi-footer__main-content-container"
             data-testid="grid">
            
                <div class="ncbi-footer__column">
                    
                        <p class="ncbi-footer__circled-icons-heading">
                            Connect with NLM
                        </p>
                    

                    <div class="ncbi-footer__circled-icons-list">
                        
                            <a href=https://twitter.com/nlm_nih class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="32"
                                     height="32"
                                     viewBox="0 0 40 40"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on X (formerly known as Twitter)</span>
                            </a>
                        

                        
                            <a href=https://www.facebook.com/nationallibraryofmedicine class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="13"
                                     height="24"
                                     viewBox="0 0 13 24"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M4.11371 23.1369C4.11371 23.082 4.11371 23.0294 4.11371 22.9745V12.9411H0.817305C0.6709 12.9411 0.670898 12.9411 0.670898 12.8016C0.670898 11.564 0.670898 10.3287 0.670898 9.09341C0.670898 8.97903 0.705213 8.95158 0.815017 8.95158C1.8673 8.95158 2.91959 8.95158 3.97417 8.95158H4.12057V8.83263C4.12057 7.8055 4.12057 6.7738 4.12057 5.74897C4.1264 4.92595 4.31387 4.11437 4.66959 3.37217C5.12916 2.38246 5.94651 1.60353 6.95717 1.1921C7.64827 0.905008 8.3913 0.764035 9.13953 0.778051C10.0019 0.791777 10.8644 0.830666 11.7268 0.860404C11.8869 0.860404 12.047 0.894717 12.2072 0.90158C12.2964 0.90158 12.3261 0.940469 12.3261 1.02968C12.3261 1.5421 12.3261 2.05452 12.3261 2.56465C12.3261 3.16857 12.3261 3.7725 12.3261 4.37642C12.3261 4.48165 12.2964 4.51367 12.1912 4.51138C11.5369 4.51138 10.8804 4.51138 10.2261 4.51138C9.92772 4.51814 9.63058 4.5526 9.33855 4.61433C9.08125 4.6617 8.84537 4.78881 8.66431 4.97766C8.48326 5.16652 8.3662 5.40755 8.32972 5.66661C8.28476 5.89271 8.26027 6.1224 8.25652 6.35289C8.25652 7.19014 8.25652 8.02969 8.25652 8.86923C8.25652 8.89439 8.25652 8.91955 8.25652 8.95615H12.0219C12.1797 8.95615 12.182 8.95616 12.1614 9.10714C12.0768 9.76596 11.9876 10.4248 11.9029 11.0813C11.8312 11.6319 11.7626 12.1824 11.697 12.733C11.6719 12.9434 11.6787 12.9434 11.4683 12.9434H8.26338V22.899C8.26338 22.979 8.26338 23.0591 8.26338 23.1392L4.11371 23.1369Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on Facebook</span>
                            </a>
                        

                        
                            <a href=https://www.youtube.com/user/NLMNIH class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="21"
                                     height="15"
                                     viewBox="0 0 21 15"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M19.2561 1.47914C18.9016 1.15888 18.5699 0.957569 17.2271 0.834039C15.5503 0.678484 13.2787 0.655608 11.563 0.65332H9.43556C7.71987 0.65332 5.4483 0.678484 3.77151 0.834039C2.43098 0.957569 2.097 1.15888 1.74242 1.47914C0.813665 2.32097 0.619221 4.62685 0.598633 6.89384C0.598633 7.31781 0.598633 7.74101 0.598633 8.16345C0.626084 10.4121 0.827391 12.686 1.74242 13.521C2.097 13.8412 2.4287 14.0425 3.77151 14.1661C5.4483 14.3216 7.71987 14.3445 9.43556 14.3468H11.563C13.2787 14.3468 15.5503 14.3216 17.2271 14.1661C18.5676 14.0425 18.9016 13.8412 19.2561 13.521C20.1712 12.6929 20.3725 10.451 20.3999 8.22064C20.3999 7.74025 20.3999 7.25986 20.3999 6.77946C20.3725 4.54907 20.1689 2.30724 19.2561 1.47914ZM8.55942 10.5311V4.65201L13.5601 7.50005L8.55942 10.5311Z"
                                          fill="white" />
                                </svg>
                                <span class="usa-sr-only">NLM on YouTube</span>
                            </a>
                        
                    </div>
                </div>
            

            
                <address class="ncbi-footer__address ncbi-footer__column">
                    
        <p>
            <a class="usa-link usa-link--external"
            href="https://www.google.com/maps/place/8600+Rockville+Pike,+Bethesda,+MD+20894/%4038.9959508,
            -77.101021,17z/data%3D!3m1!4b1!4m5!3m4!1s0x89b7c95e25765ddb%3A0x19156f88b27635b8!8m2!3d38.9959508!
            4d-77.0988323"
            rel="noopener noreferrer" target="_blank">National Library of Medicine
            <br/> 8600 Rockville Pike<br/> Bethesda, MD 20894</a>
        </p>
    
                </address>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/web_policies.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Web Policies
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nih.gov/institutes-nih/nih-office-director/office-communications-public-liaison/freedom-information-act-office" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            FOIA
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.hhs.gov/vulnerability-disclosure-policy/index.html" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS Vulnerability Disclosure
        

        
    </a>


                        </li>
                    
                </ul>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://support.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Help
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/accessibility.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Accessibility
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/careers/careers.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Careers
        

        
    </a>


                        </li>
                    
                </ul>
            
        </div>

        
            <div class="grid-row grid-col-12" data-testid="grid">
                <ul class="ncbi-footer__bottom-links-list">
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NLM
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NIH
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.hhs.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.usa.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            USA.gov
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        
    </div>
</footer>

    


        
        
    
  <script  type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/pinger/pinger.js"> </script>


    
        

<button class="back-to-top" data-ga-category="pagination" data-ga-action="back_to_top">
    <label>Back to Top</label>
    <svg class="usa-icon order-0" aria-hidden="true" focusable="false" role="img">
        <use xlink:href="/static/img/sprite.svg#arrow_upward"></use>
    </svg>
</button>
    


        
    
    
    
        
    <script type="application/javascript">
    window.ncbi = window.ncbi || {};
    window.ncbi.pmc = window.ncbi.pmc || {};
    window.ncbi.pmc.options = {
        logLevel: 'INFO',
        
        staticEndpoint: '/static/',
        
        citeCookieName: 'pmc-cf',
    };
</script>
    <script type="module" crossorigin="" src="/static/assets/base-133c6271.js"></script>
    
    <script type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/jquery/jquery-3.6.0.min.js">&#xA0;</script>
    <script type="text/javascript">
        jQuery.getScript("https://cdn.ncbi.nlm.nih.gov/core/alerts/alerts.js", function () {
            galert(['div.nav_and_browser', 'div.header', '#universal_header', '.usa-banner', 'body > *:nth-child(1)'])
        });
    </script>


    <script type="text/javascript">var exports = {};</script>
     <script src="/static/CACHE/js/output.13b077bc3ffd.js"></script>

    <script type="module" crossorigin="" src="/static/assets/article-44d04358.js"></script>
    
    

    </body>
</html>
